hg_227885.1

Basic information about the TSS

---

TSS ID: hg_227885.1 Species: human Chr: chr2		Start: 180980498 End: 180980507 Strand: +
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000410062.9 Distance: 98 GeneID: 10477 HGNC/MGI_ID: HGNC:12479 UniProt_ID: Q969T4

Gene_name: ubiquitin conjugating enzyme E2 E3 Gene_symbol: UBE2E3 Gene_synonyms: UbcH9 Gene_source: HGNC:12479

TATA-Box annotation

---

Distance to TSS:	-102
Nearest PromoterID:	NM_006357
Entrez ID:	10477
Nearest Unigene:	Hs.470804
Nearest Refseq:	NM_006357
Nearest Ensembl:	ENSG00000170035
Gene Name:	ubiquitin conjugating enzyme E2 E3
Gene Alias:	UBCH9|UbcM2
Gene Description:	ubiquitin conjugating enzyme E2 E3
Gene Type:	protein-coding
CpG%:	0.195
GC%:	0.820896
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@UBE2E3 p2@UBE2E3 p3@UBE2E3 p4@UBE2E3 p5@UBE2E3 p6@UBE2E3 p7@UBE2E3 p8@UBE2E3 p9@UBE2E3 p10@UBE2E3
Sample		p1@UBE2E3	p2@UBE2E3	p3@UBE2E3	p4@UBE2E3	p5@UBE2E3	p6@UBE2E3	p7@UBE2E3	p8@UBE2E3	p9@UBE2E3	p10@UBE2E3
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	14.81	6.04	6.04	4.87	5.06	1.36	2.14	2.34	0.78	1.95
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	19.22	3.44	5.66	3.03	2.23	0.61	1.01	3.03	0.61	1.62
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	13.89	7.33	6.37	3.47	2.70	0.96	1.35	1.35	0.58	1.54
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	13.10	4.57	5.41	4.37	2.70	0.62	1.46	1.66	0.21	1.04
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	12.82	4.95	3.82	1.80	3.37	0.22	1.35	1.35	1.12	1.57
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	12.02	5.43	3.88	2.52	4.65	0.39	0.39	2.13	0.19	0.78
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	12.86	6.54	11.55	5.66	6.54	0.44	0.65	2.40	0.87	1.74
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	13.81	3.88	6.54	4.36	3.15	0.48	0.97	0.97	1.45	0.97
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	14.53	5.56	5.98	4.06	2.56	1.50	0.64	0.64	0.43	1.92
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	15.07	2.32	4.64	5.22	4.06	1.16	1.16	0.58	1.74	0.58
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	13.34	3.23	4.04	8.08	2.43	0.81	2.02	1.21	0.40	2.83
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	10.57	4.47	1.22	2.85	2.85	1.22	0.81	0.41	0.00	1.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	43.52	20.31	3.87	3.71	2.10	3.06	2.58	0.81	0.81	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	28.42	19.40	4.66	4.06	1.05	2.56	2.10	0.75	0.30	0.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	35.79	14.71	3.51	3.95	0.66	2.63	1.54	0.00	0.44	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	36.72	18.11	5.53	5.03	2.01	3.02	2.26	0.00	0.25	1.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	32.32	15.73	5.90	5.24	0.44	3.06	2.18	0.66	0.22	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	27.84	18.56	6.33	2.11	0.84	3.80	0.84	0.00	2.11	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	20.79	18.66	3.73	4.27	1.07	3.20	2.13	0.00	0.53	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	32.34	23.62	4.51	4.21	0.60	4.06	2.26	0.60	0.90	0.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	28.87	16.44	3.47	2.94	0.94	2.94	2.00	0.80	0.67	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	28.66	22.27	4.14	4.32	0.86	2.24	1.55	0.86	0.17	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	27.53	15.12	3.88	2.33	1.29	2.07	1.42	0.90	0.90	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	33.00	15.29	3.88	3.40	0.73	2.18	0.97	0.49	0.97	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	38.96	18.06	4.90	3.61	1.81	1.55	2.32	1.81	0.52	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	30.07	19.94	2.85	4.43	0.95	3.48	2.22	0.32	0.63	0.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	20.88	14.84	6.59	6.04	0.55	1.65	1.65	0.55	0.55	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	39.84	23.81	4.72	4.01	0.94	4.01	2.83	0.47	1.41	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	32.14	22.61	4.04	3.23	0.48	3.07	1.78	0.81	0.97	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	36.37	18.82	4.89	4.16	1.45	3.98	2.53	0.36	1.09	1.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	33.49	12.14	4.61	2.09	0.63	1.67	0.42	0.84	0.84	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	33.02	20.12	3.71	4.49	1.17	2.93	1.76	0.98	0.78	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	25.53	12.66	4.43	3.80	0.42	1.69	2.11	0.84	1.06	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	16.16	12.87	6.76	1.65	1.81	0.66	1.48	0.82	0.33	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	36.46	16.64	5.05	5.24	0.75	3.55	1.68	1.12	0.37	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	44.26	14.95	4.41	3.64	0.38	3.45	1.72	0.96	0.38	0.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	47.42	19.62	4.09	3.27	1.02	2.66	2.04	1.84	2.04	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	33.04	16.12	3.83	5.44	0.60	2.82	2.01	0.60	0.20	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	42.41	13.78	4.32	3.51	2.16	3.24	1.08	0.54	0.81	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	37.21	13.44	3.12	3.12	0.48	2.40	1.20	0.96	0.72	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	35.52	18.35	2.35	2.59	0.71	3.29	1.88	0.24	0.47	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	22.69	16.84	3.37	3.07	1.17	2.64	2.20	0.15	0.29	0.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	44.92	18.35	4.85	2.32	1.05	3.37	2.11	0.84	1.48	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	45.46	20.80	3.50	3.15	1.75	4.90	1.92	1.05	0.00	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	45.98	17.87	2.61	2.41	0.80	4.62	2.21	0.40	1.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	45.13	17.91	3.95	3.02	1.63	3.02	1.86	0.70	0.70	0.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	53.26	19.91	4.32	2.40	1.68	3.36	3.36	0.72	0.72	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	37.85	17.58	3.87	3.58	0.30	4.47	2.09	0.89	0.30	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	47.64	23.46	2.87	1.20	1.20	3.11	1.68	0.48	0.48	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	35.79	19.21	2.83	3.24	0.61	2.43	1.62	0.20	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	36.48	12.71	3.69	1.84	0.61	2.46	1.23	0.61	1.23	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	39.80	12.90	2.89	2.67	0.22	2.67	1.11	1.11	1.11	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	0.00	13.99	27.98	0.00	13.99	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	26.97	9.94	2.84	1.06	0.35	0.35	1.42	1.77	0.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	22.53	11.93	2.32	2.98	0.99	0.33	2.65	0.66	0.33	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	9.23	5.87	2.52	5.87	2.52	0.84	1.68	0.00	0.00	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	20.21	10.56	4.59	2.76	2.30	2.76	2.30	0.46	0.00	1.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	35.65	6.16	1.94	0.97	1.30	0.65	0.97	1.62	0.00	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	36.29	4.82	1.28	0.64	0.64	0.64	0.00	0.64	0.64	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	38.03	14.77	2.83	2.51	0.94	1.89	1.89	0.63	1.26	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	21.86	10.58	2.82	2.12	0.71	1.41	0.00	0.71	0.71	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	11.78	6.17	1.12	2.24	0.00	0.56	0.00	1.12	0.00	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	35.83	16.72	1.59	3.98	0.00	1.59	3.18	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	25.48	10.53	1.36	2.72	2.04	1.02	1.02	0.00	0.68	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	36.39	9.42	2.92	1.62	1.62	0.00	0.32	0.97	0.32	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	28.75	10.29	1.06	0.71	1.06	0.71	1.42	0.00	0.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	16.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	0.00	0.00	7.90	0.00	7.90	0.00	7.90	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	16.58	7.80	2.44	1.95	0.98	1.46	0.49	0.98	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	13.88	8.43	3.47	1.49	0.99	0.99	1.49	1.49	0.00	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	15.95	6.10	1.88	1.88	0.47	0.00	1.41	0.47	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	38.42	8.28	3.64	3.97	1.99	0.33	0.66	0.33	0.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	19.80	9.90	3.71	1.86	1.55	0.62	1.55	0.00	1.24	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	21.71	7.95	3.06	1.83	1.22	0.31	0.31	0.00	0.31	0.00
Adipocyte - breast, donor1	11376-118A8	25.50	11.56	3.48	0.95	0.95	2.85	1.43	0.16	0.48	0.32
Adipocyte - breast, donor2	11327-117E4	30.32	12.67	1.44	1.28	0.80	3.21	1.28	0.32	0.00	0.00
Adipocyte - omental, donor1	11473-119C6	20.87	11.20	2.54	0.64	1.65	2.16	1.65	0.13	0.00	0.25
Adipocyte - omental, donor2	11474-119C7	32.89	8.22	3.74	0.00	2.24	2.99	1.49	0.00	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	30.48	9.04	2.01	2.68	0.33	1.67	0.00	0.33	0.00	0.00
Adipocyte - perirenal, donor1	11476-119C9	21.05	7.66	2.55	1.28	1.28	0.64	1.28	0.64	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	15.39	3.30	0.00	0.00	1.10	3.30	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	28.45	10.84	10.39	2.71	1.81	4.52	2.26	2.71	0.45	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	49.18	13.90	3.65	1.56	1.56	4.52	0.87	0.17	0.17	0.35
Adipocyte differentiation, day04, donor1	13019-139D4	57.30	20.54	2.54	1.56	1.96	5.87	2.15	0.00	0.20	0.20
Adipocyte differentiation, day04, donor2	13022-139D7	29.34	8.75	2.32	0.77	0.26	2.32	1.80	0.00	0.26	0.51
Adipocyte differentiation, day04, donor3	13025-139E1	37.08	13.10	3.07	1.67	2.23	2.23	1.39	0.00	0.28	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	48.79	18.81	2.94	1.76	1.18	3.53	0.59	0.59	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	58.23	21.64	4.10	2.09	2.65	7.64	2.17	0.56	0.00	0.16
Adipocyte differentiation, day08, donor2	13023-139D8	28.08	12.91	2.58	0.97	0.65	3.23	0.65	0.00	0.00	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	29.33	11.73	1.07	1.60	1.60	3.73	0.00	1.07	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	23.93	8.90	2.78	0.56	1.67	4.45	1.11	0.00	0.56	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	42.42	10.40	1.66	2.50	0.42	2.91	1.25	0.42	0.00	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	33.41	11.05	1.51	0.75	1.00	4.02	0.25	0.00	0.00	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	29.12	14.07	2.62	0.00	0.98	5.24	1.31	0.33	0.00	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	38.06	12.79	1.83	0.61	0.91	8.22	2.44	0.91	0.00	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	22.54	5.30	2.87	2.43	1.33	1.33	2.21	0.66	0.88	0.88
Alveolar Epithelial Cells, donor2	11590-120G6	25.10	6.81	3.59	4.30	1.08	1.08	0.36	0.36	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	16.77	2.40	1.20	1.20	0.00	0.00	1.20	1.20	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	37.96	8.10	2.88	2.52	1.62	0.72	2.88	0.90	0.18	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	38.49	10.04	3.35	0.00	1.67	0.00	3.35	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	43.76	11.09	2.26	1.64	0.41	1.44	2.67	0.62	0.21	0.00
Anulus Pulposus Cell, donor1	11248-116E6	29.64	18.65	13.50	10.76	4.35	6.87	1.72	3.89	4.00	3.78
Anulus Pulposus Cell, donor2	11463-119B5	40.41	14.45	12.00	12.00	1.96	7.35	0.73	5.14	3.18	1.22
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	23.81	4.04	5.84	4.04	0.45	0.90	0.90	0.45	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	26.92	5.21	4.78	3.91	0.87	1.30	2.17	1.30	0.00	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	4.28	2.14	4.28	4.28	2.14	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	21.22	4.18	4.48	3.29	2.09	0.30	0.30	0.00	0.60	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	25.29	6.32	2.53	2.53	1.26	0.00	2.53	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	19.80	2.64	3.30	1.32	1.32	0.66	0.66	1.32	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	15.59	5.20	1.62	2.92	0.32	1.30	0.32	0.32	0.65	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	19.42	2.91	5.83	3.40	1.94	0.00	2.91	1.94	1.46	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	12.47	3.56	1.78	1.78	3.56	0.00	0.59	1.19	0.00	1.19
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	23.73	3.39	4.52	4.90	1.51	1.13	1.51	0.75	0.75	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	23.95	7.98	0.73	2.90	2.18	2.18	2.18	2.18	0.73	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	12.54	1.25	1.25	2.51	2.51	0.00	2.51	2.51	1.25	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	16.80	4.45	3.79	2.14	2.47	1.65	1.15	1.15	1.48	0.99
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	19.11	4.09	1.36	8.19	1.36	4.09	0.00	2.73	1.36	1.36
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	23.22	4.37	4.52	2.71	1.51	0.45	1.36	1.21	0.90	0.60
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	20.36	9.11	5.89	3.75	1.07	1.61	1.61	2.14	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	24.56	3.40	3.97	2.65	2.27	1.32	1.13	0.76	0.57	0.19
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	19.24	4.28	5.61	3.21	1.07	0.27	0.53	1.07	0.53	0.53
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	18.53	5.85	1.95	1.95	2.93	0.00	0.00	1.95	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	23.88	3.98	2.82	3.32	1.33	0.50	1.16	0.66	0.50	0.17
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	12.01	0.00	2.40	2.40	1.20	0.00	0.00	1.20	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	17.70	0.00	0.00	7.08	3.54	3.54	3.54	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	28.65	6.52	2.57	3.60	1.72	1.37	1.03	0.86	0.69	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	20.97	4.19	0.00	0.00	0.00	0.00	8.39	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	16.02	5.34	4.37	5.34	1.46	1.94	0.49	1.46	1.94	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	24.66	4.17	6.45	3.79	1.90	1.90	0.76	0.38	0.76	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	18.17	2.42	3.63	3.63	0.00	1.21	2.42	0.00	1.21	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	23.37	4.56	1.14	4.56	1.71	0.57	0.57	1.14	0.57	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	22.23	5.56	3.85	2.35	0.64	1.50	1.50	1.07	0.64	0.86
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	18.07	4.39	3.10	2.32	2.06	0.77	1.03	1.55	0.77	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	26.28	4.22	2.82	5.63	1.41	1.41	0.47	0.47	1.41	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	28.94	3.86	2.89	3.22	1.93	0.32	1.29	0.00	0.32	0.64
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	17.12	2.14	2.14	4.99	0.71	2.14	2.14	0.71	0.00	1.43
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	19.30	2.34	3.51	1.17	1.17	0.58	0.00	1.17	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	29.51	3.61	2.71	2.71	1.51	1.51	1.20	1.20	0.60	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	23.76	4.75	3.56	4.75	2.38	0.00	0.00	0.00	2.38	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	24.41	3.05	4.58	5.59	2.03	0.51	0.51	0.00	0.51	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	29.03	6.11	3.31	1.27	1.02	0.25	0.51	1.02	0.25	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	17.15	1.91	3.81	1.91	0.64	0.64	0.00	1.27	1.27	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	21.15	4.75	6.04	2.59	1.73	0.00	0.43	0.43	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	26.67	3.60	3.39	2.12	2.12	1.06	0.42	0.85	0.85	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	20.30	3.19	2.90	1.45	1.45	0.00	0.58	1.45	0.87	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	34.01	5.67	3.78	1.89	1.89	0.94	0.94	0.94	2.83	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	25.94	4.58	2.54	3.22	0.85	1.86	1.02	1.02	0.34	0.85
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	11.58	2.32	4.63	2.32	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	35.91	2.11	12.68	2.11	2.11	6.34	0.00	0.00	4.23	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	27.02	5.15	3.00	4.29	1.07	1.29	1.50	0.43	0.21	0.43
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	19.25	4.81	3.61	1.80	1.20	0.60	3.01	0.60	0.60	1.20
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	17.50	3.64	6.56	5.83	1.46	1.46	2.19	0.73	0.73	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	19.08	4.60	3.68	3.22	2.07	0.92	0.46	1.15	0.00	0.92
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	15.30	0.00	2.55	2.55	0.00	0.00	0.00	5.10	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	22.88	2.54	3.31	1.53	2.03	1.27	1.02	1.53	1.53	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	20.23	5.57	3.92	3.72	1.86	2.68	0.41	2.48	1.86	0.21
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	16.52	3.06	2.45	2.14	2.14	1.22	1.22	0.61	1.22	0.61
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	20.55	3.35	4.30	8.60	0.48	0.96	0.48	0.96	0.48	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	26.61	3.55	4.43	3.99	0.44	2.00	0.67	0.89	0.44	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	22.89	0.00	4.58	1.53	3.05	1.53	1.53	1.53	0.00	3.05
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	18.83	4.98	6.09	3.88	2.22	1.66	0.55	1.11	1.66	1.11
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	23.04	5.56	3.18	1.32	0.79	0.26	1.32	0.00	0.79	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	14.54	3.27	4.36	1.09	0.36	0.73	0.36	1.82	2.54	0.36
Astrocyte - cerebellum, donor1	11500-119F6	44.58	5.16	9.95	2.33	3.32	4.79	0.37	2.33	1.47	0.37
Astrocyte - cerebellum, donor2	11580-120F5	71.20	6.16	5.13	5.13	0.51	4.11	0.51	2.74	1.88	0.34
Astrocyte - cerebellum, donor3	11661-122F5	31.67	4.19	3.15	1.89	1.89	2.31	1.05	0.84	1.05	1.05
Astrocyte - cerebral cortex, donor1	11235-116D2	37.30	8.71	11.15	2.79	2.44	3.83	0.35	3.83	2.44	0.35
Astrocyte - cerebral cortex, donor2	11316-117D2	43.36	10.35	8.25	3.40	4.85	1.62	1.94	2.91	2.59	1.94
Astrocyte - cerebral cortex, donor3	11392-118C6	52.65	6.26	6.12	2.68	2.39	1.64	0.75	6.56	2.98	1.94
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	44.04	9.06	1.26	0.80	1.38	0.11	1.72	0.00	0.00	0.11
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	65.65	8.14	1.38	0.13	2.63	0.88	2.13	0.25	0.25	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	56.90	8.65	0.91	0.80	2.28	0.57	2.05	0.46	0.00	0.00
Basophils, donor1	12241-129G9	23.28	3.92	3.14	2.09	1.31	0.00	1.31	0.00	0.26	0.00
Basophils, donor2	12242-129H1	28.86	6.49	6.86	2.16	2.89	0.36	1.44	0.00	0.36	0.00
Basophils, donor3	12243-129H2	32.34	6.32	1.76	3.09	1.03	0.15	1.91	0.15	0.15	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	21.78	6.47	3.23	1.94	1.29	1.51	1.29	0.22	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	14.63	3.20	1.37	4.57	0.46	0.46	0.91	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	14.35	7.17	7.17	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	20.71	3.77	4.39	5.02	5.02	0.63	0.00	1.26	0.63	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	32.02	5.20	3.33	3.54	1.46	0.62	0.62	0.42	0.42	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	15.43	2.53	1.38	3.22	1.38	0.00	0.46	0.00	0.23	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	21.59	3.78	2.16	3.06	1.26	0.36	0.54	0.36	0.00	0.18
Burkitt's lymphoma cell line:DAUDI	10422-106C8	18.24	2.16	1.34	1.24	3.30	0.00	0.62	0.72	0.10	0.31
Burkitt's lymphoma cell line:RAJI	10476-106I8	13.74	0.00	0.93	0.93	3.49	0.00	0.00	0.23	0.00	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	30.06	13.75	5.12	3.20	3.20	1.92	2.24	0.64	1.60	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	41.37	0.00	10.34	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	16.91	5.64	3.94	6.20	2.25	1.69	1.69	0.00	0.00	0.56
CD14+ Monocytes, donor2	11305-117B9	41.02	5.20	3.16	2.97	2.23	0.56	1.11	0.00	0.19	0.93
CD14+ Monocytes, donor3	11381-118B4	31.61	7.68	1.98	4.17	1.32	0.00	0.66	0.44	0.00	0.88
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	21.51	6.79	1.13	1.42	0.57	0.28	1.70	0.00	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	21.99	7.96	0.76	2.27	1.52	0.00	1.90	0.00	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	35.83	6.57	1.31	1.64	0.66	0.99	1.31	0.33	0.00	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	38.59	6.50	2.46	3.90	1.30	0.29	1.30	0.00	0.00	0.14
CD14+ monocytes - mock treated, donor2	11873-125C1	30.17	6.64	2.72	2.72	0.60	0.60	0.60	0.00	0.00	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	37.43	4.74	4.74	3.55	1.42	0.00	0.71	0.00	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	26.11	2.68	2.51	3.01	0.33	0.17	1.17	0.00	0.00	0.17
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	20.42	4.42	1.93	1.93	0.55	0.00	0.00	0.28	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	22.31	2.48	4.71	1.98	0.25	0.50	0.25	0.00	0.00	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	20.17	2.55	2.74	2.55	0.20	0.59	1.37	0.00	0.00	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	16.38	3.20	1.60	3.92	0.53	0.18	0.89	0.00	0.00	0.18
CD14+ monocytes - treated with BCG, donor3	11880-125C8	16.76	1.74	4.35	3.70	1.74	0.00	0.65	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	15.22	2.11	2.34	2.81	0.47	0.00	0.94	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	13.20	1.58	4.75	3.17	0.53	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	15.53	2.22	6.66	1.11	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	22.16	3.42	3.27	4.46	1.34	0.15	0.89	0.00	0.00	0.15
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	22.95	3.19	2.39	1.20	0.40	0.20	0.20	0.20	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	19.99	1.87	5.00	4.58	1.25	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	23.79	4.80	1.83	3.20	0.69	0.46	0.69	0.69	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	18.32	3.39	2.04	1.81	0.45	0.23	0.45	0.00	0.00	0.23
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	13.53	3.49	3.49	2.18	0.00	0.44	0.87	0.00	0.00	0.44
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	25.55	4.30	3.23	3.77	0.54	0.00	0.54	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	29.66	3.49	2.27	2.79	0.35	0.00	1.22	0.17	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	26.51	2.95	3.79	1.68	0.84	0.42	0.84	0.00	0.00	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	19.29	2.57	1.65	2.20	0.92	0.00	0.37	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	21.14	1.06	2.47	2.82	1.06	0.00	0.35	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	23.69	3.95	3.51	3.51	0.88	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	18.13	2.96	2.27	2.09	0.87	0.00	0.70	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	17.47	2.23	1.49	1.86	0.37	0.00	0.37	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	16.60	3.66	4.74	4.74	0.65	0.65	0.00	0.22	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	20.88	3.28	1.64	3.28	0.41	0.82	0.41	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	12.75	1.62	3.25	1.85	0.23	0.00	0.70	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	11.60	1.39	4.41	1.62	1.16	0.46	0.70	0.46	0.00	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	13.08	2.18	2.83	3.05	0.87	0.22	1.53	0.22	0.00	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	16.17	3.00	4.85	3.70	1.62	0.69	0.92	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	16.25	3.47	1.95	2.38	0.43	0.22	1.73	0.00	0.00	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	21.49	6.85	3.58	5.29	0.93	0.31	1.87	0.16	0.16	0.16
CD14+CD16- Monocytes, donor2	11799-124C8	23.75	5.06	3.67	5.94	1.40	0.52	1.22	0.00	0.00	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	33.89	8.03	3.57	3.34	1.56	0.22	1.78	0.00	0.22	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	23.99	3.83	4.08	2.30	0.77	0.00	0.26	0.26	0.00	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	21.30	4.17	7.25	5.49	1.32	0.22	0.66	0.22	0.00	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	22.53	3.58	3.79	3.16	0.42	0.00	2.32	0.21	0.21	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	32.52	10.16	0.00	0.00	2.03	0.00	2.03	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	16.27	6.10	1.36	0.68	6.10	0.00	2.71	0.00	0.00	0.68
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	19.68	3.11	0.00	0.00	3.11	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	21.32	9.06	1.60	0.53	2.13	0.00	0.53	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	28.41	11.79	0.54	1.07	5.90	0.00	3.22	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	28.08	8.42	0.00	0.00	2.11	0.00	3.51	0.00	0.70	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	17.26	7.84	1.57	0.00	1.57	0.78	3.92	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	23.73	5.27	0.00	0.00	2.64	0.00	1.32	1.32	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	41.10	3.29	1.64	0.00	2.47	0.82	0.82	0.00	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	31.19	5.80	1.45	0.00	2.18	0.00	4.35	0.00	0.00	0.73
CD19+ B Cells, donor3	11705-123B4	31.30	8.08	1.01	0.00	2.02	0.50	0.50	0.50	0.00	0.50
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	70.31	18.18	10.91	2.42	6.46	2.02	3.23	0.40	0.00	0.40
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	61.12	12.78	8.39	1.20	5.59	2.00	2.00	0.00	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	13.05	7.03	3.01	6.02	5.02	3.01	0.00	1.00	0.00	2.01
CD34+ Progenitors, donor2	11625-122B5	12.36	8.43	10.11	6.74	2.81	0.56	0.00	1.12	3.93	0.56
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	30.06	10.52	5.64	4.88	1.13	0.38	3.01	1.13	1.88	0.38
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	28.86	11.73	5.41	3.61	2.48	1.58	3.83	0.90	0.68	0.23
CD4+ T Cells, donor1	11225-116C1	27.14	10.71	1.07	0.36	2.14	0.71	1.79	0.00	0.36	0.36
CD4+ T Cells, donor2	11306-117C1	32.46	6.74	0.61	1.22	3.06	0.61	1.84	0.00	0.00	0.00
CD4+ T Cells, donor3	11382-118B5	29.58	4.88	1.52	0.30	1.83	0.00	0.30	0.61	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	21.18	3.57	1.28	1.02	0.77	0.00	0.77	0.26	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	26.50	4.94	1.35	0.67	1.35	0.00	2.25	0.67	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	31.33	5.17	0.86	0.00	2.30	0.29	2.59	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	23.23	6.16	1.42	0.47	1.90	0.47	0.95	0.47	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	25.28	11.94	0.00	0.00	1.40	0.00	3.51	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	29.67	3.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	27.60	3.03	2.31	1.59	2.31	0.14	1.73	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	58.63	2.37	1.19	0.68	1.69	0.17	1.69	0.00	0.17	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	52.39	3.22	1.45	0.32	2.26	0.00	0.64	0.16	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	8.97	3.14	0.45	0.45	0.90	0.00	0.45	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	11.18	2.45	0.35	0.35	0.35	0.00	0.00	0.35	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	11.88	4.84	0.00	0.44	0.44	0.00	0.88	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	16.02	2.53	1.26	1.26	2.95	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	40.52	4.16	1.87	1.04	2.08	0.21	0.62	0.21	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	31.74	4.01	1.34	0.33	1.67	0.33	1.67	0.00	0.00	0.33
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	19.58	7.07	1.36	0.27	4.08	0.00	0.54	0.54	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	35.91	3.22	2.68	1.07	3.75	1.61	1.07	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	41.24	5.38	1.79	3.59	5.38	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	38.57	4.08	2.41	0.93	2.60	0.19	0.56	0.19	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	46.14	3.68	2.82	0.87	2.17	0.00	2.17	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	55.27	5.46	1.26	1.89	3.57	0.21	2.10	0.00	0.00	0.21
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	22.25	4.04	0.00	0.00	0.51	0.00	1.52	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	20.80	5.63	0.43	0.00	3.03	0.43	1.30	0.43	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	25.28	4.36	2.18	0.44	1.74	0.44	0.44	0.00	0.44	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	27.22	12.37	0.00	0.49	4.45	0.99	1.48	0.00	0.49	0.49
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	33.23	7.39	0.00	0.92	3.69	0.92	2.77	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	32.10	6.98	4.19	0.00	6.98	0.00	4.19	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	24.65	8.03	2.22	0.55	3.05	0.55	1.94	0.00	0.28	0.55
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	32.15	9.32	1.96	2.70	2.21	0.49	0.98	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	21.56	3.08	4.62	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	24.71	7.52	0.72	0.36	1.79	0.00	1.43	0.36	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	41.55	18.00	0.00	1.38	2.77	0.00	0.00	1.38	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	34.70	13.42	1.96	1.31	4.58	1.31	1.64	0.33	0.33	0.33
CD8+ T Cells, donor2	11307-117C2	54.44	9.01	1.50	0.75	4.51	1.50	0.75	0.38	0.00	0.00
CD8+ T Cells, donor3	11383-118B6	51.76	15.15	1.01	1.26	2.27	1.01	1.01	1.01	0.25	0.50
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	10.09	5.05	0.46	1.61	0.46	0.23	0.92	0.00	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	6.95	6.23	0.72	2.16	0.48	0.24	0.96	0.00	0.24	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	4.10	6.57	0.82	1.37	0.55	0.27	1.09	0.00	0.27	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	3.90	3.90	0.90	2.10	0.60	0.60	0.90	0.00	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	7.20	5.04	1.92	0.96	0.96	0.48	1.44	0.48	0.48	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	8.41	5.46	0.23	0.91	1.59	0.68	0.91	0.00	0.00	0.23
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	8.69	8.04	2.17	1.52	1.09	0.22	0.65	0.43	0.22	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	7.63	6.84	1.58	1.84	0.00	0.00	0.79	0.79	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	8.91	5.86	1.64	2.35	0.47	0.47	2.58	0.23	0.23	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	7.55	9.06	0.30	2.42	0.91	0.30	0.60	1.51	0.30	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	6.97	6.10	2.03	3.20	0.58	0.87	1.45	0.00	0.58	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	13.59	8.53	1.33	2.40	0.00	0.00	1.60	0.80	0.53	0.27
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	7.00	3.06	0.00	1.75	1.31	0.00	0.44	0.88	0.88	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	4.55	2.28	0.91	0.91	0.46	0.46	0.46	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	9.70	0.75	2.24	2.98	1.49	0.75	2.24	2.24	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	10.08	3.60	1.44	1.08	0.36	0.72	0.36	0.36	0.00	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	8.34	6.04	1.15	0.29	1.15	0.00	0.58	0.00	0.29	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	5.66	4.95	1.65	1.41	0.47	0.00	0.94	0.94	0.00	0.24
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	6.97	5.39	1.27	2.22	0.00	0.32	1.27	0.32	1.27	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	10.46	6.77	0.31	1.54	0.62	0.00	1.85	0.62	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	7.37	6.73	1.60	3.53	0.64	0.64	1.92	0.00	0.32	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	7.27	4.21	1.15	1.91	0.76	0.00	1.53	0.38	1.15	0.38
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	11.43	6.70	0.79	1.97	0.00	0.00	1.58	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	8.32	3.78	1.51	3.03	0.00	0.76	0.76	0.76	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	0.80	0.80	0.00	0.80	0.80	0.00	0.00	0.00	0.80	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	6.29	3.50	0.70	1.40	1.40	0.70	2.10	0.00	0.00	0.70
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	7.01	4.01	1.00	2.00	0.00	0.00	3.01	2.00	1.00	1.00
Cardiac Myocyte, donor1	11525-119I4	53.00	20.11	7.31	9.14	1.83	12.79	3.66	1.83	3.66	3.66
Cardiac Myocyte, donor2	11605-120I3	27.17	7.41	2.96	7.41	0.49	3.95	0.49	0.49	0.49	0.49
Cardiac Myocyte, donor3	11686-122I3	17.68	6.21	3.05	3.58	1.79	2.10	0.21	0.84	0.84	0.32
Chondrocyte - de diff, donor1	11261-116G1	54.43	7.28	5.20	1.39	2.77	4.16	0.35	0.35	0.35	0.00
Chondrocyte - de diff, donor2	11338-117F6	18.48	6.75	4.62	1.07	1.07	1.42	0.36	0.71	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	30.61	12.97	2.73	2.16	1.37	3.41	0.68	0.80	0.23	0.23
Chondrocyte - re diff, donor2	11339-117F7	39.39	17.01	5.37	6.27	2.69	3.58	1.79	0.90	0.90	0.90
Chondrocyte - re diff, donor3	11411-118E7	30.33	9.71	2.02	1.62	2.43	1.62	1.62	0.40	0.40	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	35.00	9.75	11.02	5.85	5.39	1.95	2.64	7.46	4.36	2.98
Ciliary Epithelial Cells, donor2	11323-117D9	42.54	13.47	7.05	3.42	3.42	2.78	1.07	5.13	1.92	2.14
Ciliary Epithelial Cells, donor3	11399-118D4	41.42	10.53	5.75	3.81	2.65	2.48	1.86	4.42	3.01	2.21
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	48.51	6.69	6.97	3.39	2.84	1.74	1.01	1.56	1.19	0.73
Corneal Epithelial Cells, donor1	11526-119I5	17.79	5.49	1.54	4.17	1.76	0.66	1.98	0.00	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	22.75	2.28	0.00	3.41	2.28	0.00	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	29.91	5.37	2.30	2.81	1.28	1.02	0.26	0.26	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	11.56	1.98	2.15	1.49	1.16	0.00	0.99	0.17	0.17	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	9.78	4.42	0.63	1.58	0.95	0.00	0.32	0.32	0.00	0.32
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	10.35	10.35	0.00	3.45	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	13.71	2.92	0.97	2.16	0.11	0.00	0.65	0.00	0.11	0.00
Dendritic Cells - plasmacytoid, donor1	11228-116C4	30.41	13.67	11.62	4.78	15.03	0.68	5.12	5.12	3.76	1.02
Dendritic Cells - plasmacytoid, donor2	11309-117C4	22.20	10.45	5.88	3.26	11.10	1.31	5.88	4.57	6.53	2.61
Dendritic Cells - plasmacytoid, donor3	11385-118B8	27.10	7.74	9.19	5.81	13.07	0.97	1.94	4.36	2.42	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	18.34	5.84	2.84	3.84	2.00	1.33	0.83	0.83	0.17	0.50
Endothelial Cells - Aortic, donor1	11263-116G3	19.36	6.45	2.35	5.28	0.59	1.17	1.17	2.35	0.00	0.59
Endothelial Cells - Aortic, donor2	11340-117F8	22.34	9.33	1.98	5.94	1.41	1.41	2.26	1.98	0.57	0.28
Endothelial Cells - Aortic, donor3	11412-118E8	26.34	4.33	1.57	5.90	2.36	3.54	1.18	2.36	0.00	0.39
Endothelial Cells - Artery, donor1	11264-116G4	37.23	4.07	2.04	2.62	1.16	1.45	1.16	0.58	0.29	0.00
Endothelial Cells - Artery, donor2	11341-117F9	32.94	8.23	2.82	4.71	0.94	1.41	1.88	0.71	1.41	0.00
Endothelial Cells - Artery, donor3	11413-118E9	25.60	7.54	3.33	5.96	1.93	1.58	1.58	1.75	1.40	0.70
Endothelial Cells - Lymphatic, donor1	11236-116D3	14.63	6.87	2.22	5.32	2.66	1.11	0.44	1.77	1.99	0.44
Endothelial Cells - Lymphatic, donor2	11317-117D3	22.52	7.00	1.83	1.52	2.43	2.43	1.83	0.91	1.22	0.61
Endothelial Cells - Lymphatic, donor3	11393-118C7	23.12	6.20	3.66	4.23	2.26	1.13	0.56	0.85	0.28	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	12.18	3.57	2.97	2.67	1.49	0.59	1.19	1.19	0.89	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	13.54	2.08	1.56	1.56	1.56	0.52	0.00	0.52	0.00	0.52
Endothelial Cells - Microvascular, donor3	11414-118F1	26.80	4.54	1.84	2.41	0.99	1.13	0.99	0.43	0.43	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	26.81	8.00	4.80	2.40	2.40	1.20	0.00	0.40	0.40	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	31.45	4.19	4.19	4.19	2.10	2.10	1.05	0.00	0.52	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	30.44	17.02	5.09	9.82	3.48	4.85	3.73	0.37	1.24	0.37
Endothelial Cells - Umbilical vein, donor2	11324-117E1	51.06	11.95	3.69	6.08	3.26	3.26	1.74	0.43	1.52	0.43
Endothelial Cells - Umbilical vein, donor3	11400-118D5	66.93	21.37	2.93	8.92	2.08	5.13	2.56	0.98	0.73	0.73
Endothelial Cells - Vein, donor1	11267-116G7	32.99	9.10	1.14	2.28	1.14	3.41	1.14	2.28	0.00	2.28
Endothelial Cells - Vein, donor2	11344-117G3	13.27	4.19	2.79	2.79	0.00	1.40	0.70	0.70	2.79	0.00
Endothelial Cells - Vein, donor3	11416-118F3	32.66	5.81	3.14	7.38	1.88	0.79	1.26	1.57	0.94	1.41
Eosinophils, donor1	12244-129H3	30.49	15.25	0.00	0.00	0.00	15.25	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	39.61	1.65	3.30	3.30	0.00	1.65	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	21.40	3.57	3.57	3.57	0.00	3.57	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	12.70	6.35	2.69	3.42	1.22	0.49	0.98	0.24	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	29.12	2.08	4.16	6.24	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	48.81	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	41.46	10.67	1.64	0.82	1.23	1.23	2.87	0.41	0.00	0.82
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	20.58	5.47	1.42	1.42	0.66	1.75	0.00	0.22	0.11	0.33
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	60.34	12.57	3.90	3.68	1.41	4.33	1.30	0.98	0.54	0.33
Fibroblast - Aortic Adventitial, donor1	11245-116E3	14.80	6.67	3.15	2.55	2.18	1.58	0.61	0.61	0.73	0.73
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	11.60	5.19	3.55	1.23	0.55	1.23	0.27	0.00	0.00	0.00
Fibroblast - Aortic Adventitial, donor2	11326-117E3	29.21	7.07	2.74	1.58	1.48	1.37	0.42	0.21	0.32	0.11
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	15.81	7.11	6.59	3.95	1.58	3.16	0.26	0.26	0.00	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	40.53	13.29	6.31	5.32	1.66	2.33	1.33	1.99	1.33	1.66
Fibroblast - Cardiac, donor1	11268-116G8	29.49	9.53	4.08	3.18	1.36	4.99	0.45	4.99	2.27	1.81
Fibroblast - Cardiac, donor2	11345-117G4	18.95	3.03	2.27	0.76	2.27	0.00	1.52	1.52	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	28.86	10.88	2.84	2.21	1.73	2.52	1.89	0.63	1.10	0.32
Fibroblast - Cardiac, donor4	11452-119A3	38.49	21.22	2.73	2.73	1.52	8.79	2.12	3.64	1.52	1.82
Fibroblast - Cardiac, donor5	11456-119A7	33.88	8.50	5.33	6.22	2.54	3.17	0.89	2.03	1.52	0.38
Fibroblast - Cardiac, donor6	11460-119B2	42.60	8.64	4.24	6.22	3.03	3.18	0.30	3.49	1.52	0.61
Fibroblast - Choroid Plexus, donor1	11492-119E7	30.42	6.57	5.23	1.74	2.14	4.56	0.94	3.35	1.34	0.54
Fibroblast - Choroid Plexus, donor2	11572-120E6	32.36	6.47	7.33	3.45	3.02	4.31	0.86	5.61	3.45	2.16
Fibroblast - Choroid Plexus, donor3	11653-122E6	32.23	8.79	2.93	4.39	4.39	1.46	0.00	0.00	2.93	1.46
Fibroblast - Conjunctival, donor1	11531-120A1	44.28	7.84	5.30	3.92	1.85	1.61	0.69	0.69	0.69	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	28.49	10.85	6.78	1.70	1.70	2.54	0.17	1.36	0.85	0.17
Fibroblast - Dermal, donor1	11269-116G9	35.22	13.38	6.57	4.93	1.88	3.76	0.94	2.58	2.35	0.94
Fibroblast - Dermal, donor2	11346-117G5	21.23	7.08	7.55	3.77	4.25	2.36	0.47	5.19	1.42	1.89
Fibroblast - Dermal, donor3	11418-118F5	45.09	10.76	7.74	8.34	2.18	4.47	2.06	5.92	3.63	3.63
Fibroblast - Dermal, donor4	11450-119A1	61.27	7.57	9.04	7.57	3.39	1.81	0.45	2.15	1.24	0.34
Fibroblast - Dermal, donor5	11454-119A5	54.25	6.45	6.11	6.63	2.97	0.70	1.05	0.87	1.40	0.87
Fibroblast - Dermal, donor6	11458-119A9	66.76	6.98	7.80	7.63	2.60	1.79	1.79	2.44	1.14	0.32
Fibroblast - Gingival, donor1	11237-116D4	41.02	19.99	8.95	6.87	3.96	11.45	4.58	4.58	2.08	4.58
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	61.57	24.10	8.65	9.69	3.14	13.36	3.41	5.24	1.31	2.36
Fibroblast - Gingival, donor2	11318-117D4	50.08	12.52	7.64	6.85	2.64	4.61	2.50	4.22	3.29	3.03
Fibroblast - Gingival, donor3	11394-118C8	86.05	23.40	7.25	8.03	3.38	12.09	2.22	4.06	2.51	2.61
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	37.40	15.58	2.08	4.16	2.08	2.08	0.00	0.00	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	40.17	11.10	2.64	1.76	1.59	1.76	1.76	0.53	0.18	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	65.16	20.73	7.33	5.92	2.81	9.35	3.43	4.99	3.27	1.87
Fibroblast - Gingival, donor6 (control)	11922-125H5	47.60	13.66	7.57	5.54	2.98	5.54	2.98	2.03	0.81	0.68
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	135.51	50.81	2.47	1.06	2.12	16.59	10.23	0.71	0.35	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	64.64	21.35	7.90	5.26	2.63	12.58	3.36	2.05	0.88	2.34
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	34.63	13.77	4.23	2.05	1.09	4.23	2.18	0.27	0.55	0.41
Fibroblast - Gingival, donor8 (control)	11926-125H9	54.30	13.38	3.29	3.62	2.52	4.28	2.52	0.55	0.11	0.22
Fibroblast - Gingival, donor9 (control)	11927-125I1	72.64	15.99	4.84	2.79	2.93	3.08	1.03	0.44	0.73	0.15
Fibroblast - Lung, donor1	11270-116H1	24.47	5.44	4.08	6.80	4.08	0.00	1.36	4.08	1.36	2.72
Fibroblast - Lung, donor2	11347-117G6	49.24	16.41	22.38	10.45	1.49	10.45	4.48	16.41	7.46	5.97
Fibroblast - Lung, donor3	11419-118F6	67.32	21.31	10.97	10.13	3.17	8.86	2.53	11.82	6.33	5.49
Fibroblast - Lymphatic, donor1	11506-119G3	43.32	17.49	4.17	1.67	1.67	6.66	0.83	0.00	0.83	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	47.55	8.39	0.00	2.80	0.00	2.80	0.00	2.80	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	16.51	6.16	0.84	1.96	1.12	1.40	1.12	0.00	0.00	0.28
Fibroblast - Mammary, donor1	11540-120B1	65.36	23.14	6.50	4.47	0.81	5.68	4.87	4.47	0.81	0.81
Fibroblast - Mammary, donor2	11620-122A9	59.91	7.99	0.00	11.98	0.00	0.00	3.99	0.00	0.00	3.99
Fibroblast - Mammary, donor3	11701-123A9	59.56	5.96	5.96	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	32.98	12.03	10.28	8.34	3.88	5.24	1.16	6.01	4.27	3.69
Fibroblast - Periodontal Ligament, donor2	11319-117D5	76.75	16.69	8.95	6.37	2.73	4.70	2.58	4.10	2.73	3.34
Fibroblast - Periodontal Ligament, donor3	11395-118C9	58.14	17.44	6.73	3.98	1.22	7.34	1.84	2.45	0.61	0.92
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	68.69	16.79	4.20	3.05	1.53	1.53	1.91	1.53	0.38	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	35.91	12.42	2.43	3.24	1.08	2.43	1.62	0.81	0.81	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	49.52	16.82	3.13	3.25	1.04	3.60	2.55	0.46	0.46	0.46
Fibroblast - Pulmonary Artery, donor1	11250-116E8	24.54	8.95	6.96	4.42	3.54	2.87	1.44	2.21	0.88	0.77
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	57.71	17.68	4.88	4.47	1.83	4.88	3.86	1.83	1.42	0.61
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	44.10	12.03	2.00	2.67	1.34	3.34	1.34	0.67	0.67	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	38.35	12.26	5.93	4.35	1.98	1.98	1.19	2.37	0.79	0.79
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	23.02	11.31	13.69	4.76	2.58	5.16	1.39	0.99	0.99	0.20
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	30.91	14.39	6.75	2.84	1.60	6.75	1.42	1.95	0.53	1.60
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	30.75	9.85	6.11	3.74	0.99	3.55	1.97	0.39	0.59	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	24.07	9.33	10.83	8.12	1.20	4.81	1.20	2.71	0.90	1.20
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	51.82	16.62	9.93	5.72	3.89	11.01	1.51	2.37	1.73	0.97
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	18.22	5.57	6.83	4.05	1.52	4.30	1.01	0.00	0.25	0.00
Fibroblast - skin normal, donor1	11553-120C5	30.85	16.08	7.88	3.94	1.80	7.06	1.80	1.48	1.31	0.98
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	32.88	10.23	8.22	3.61	2.21	5.21	1.60	1.20	1.00	1.40
Fibroblast - skin normal, donor2	11561-120D4	31.55	8.94	7.23	2.81	1.31	4.92	0.90	0.90	0.60	0.00
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	26.60	8.16	12.69	5.74	2.12	3.93	0.91	0.00	0.30	0.30
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	38.61	22.20	6.96	3.07	2.90	6.05	2.32	1.99	0.91	1.33
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	34.19	13.16	6.50	2.91	1.20	4.10	0.85	0.51	0.34	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	26.93	5.58	7.88	2.30	1.31	2.96	0.99	0.66	0.33	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	31.21	10.87	8.31	3.83	3.30	5.97	1.28	3.83	1.07	0.75
Fibroblast - skin walker warburg, donor1	11554-120C6	26.82	9.11	5.57	2.87	2.19	3.88	1.35	1.35	0.67	0.67
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	34.03	20.07	4.55	5.96	2.04	4.55	2.20	0.78	0.94	0.94
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	44.32	0.00	0.00	0.00	22.16	0.00	0.00	22.16	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	99.35	3.49	8.72	0.87	1.74	0.87	0.87	0.00	0.00	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	35.02	12.14	5.20	5.37	1.56	1.56	5.37	1.56	0.87	0.87
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	34.35	5.73	4.16	3.90	0.52	1.04	3.12	0.78	1.04	0.26
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	56.72	15.33	3.32	2.81	2.04	2.30	6.13	0.77	1.28	1.28
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	28.33	7.66	18.37	10.72	3.83	0.77	2.30	11.48	8.42	3.83
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	28.71	3.19	31.27	10.21	6.38	1.28	2.55	9.57	9.57	4.47
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	86.15	14.55	22.82	8.27	9.41	0.57	3.14	4.28	7.13	1.71
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	61.22	7.17	48.53	15.17	7.72	0.00	3.86	12.96	13.79	4.41
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	66.67	4.79	21.01	8.90	4.11	0.46	2.74	10.05	6.16	1.37
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	89.36	14.07	22.59	6.93	8.72	1.19	5.75	7.73	5.75	3.17
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	60.27	5.82	33.31	15.07	8.72	0.53	3.17	13.22	10.31	6.87
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	77.62	1.96	23.16	7.50	1.63	0.65	0.98	8.48	9.13	1.63
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	70.31	14.15	15.48	8.84	10.17	0.44	7.52	3.54	6.63	2.21
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	18.80	6.08	12.01	6.64	3.25	0.14	2.54	4.95	3.25	1.70
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	17.24	7.02	12.93	7.76	2.46	0.62	2.71	5.30	2.83	2.71
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	20.68	6.98	12.63	5.37	3.76	0.27	1.88	3.22	2.95	1.34
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	20.19	6.69	8.42	7.81	2.85	0.87	2.48	6.44	3.84	2.60
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	14.95	4.43	10.24	7.06	2.08	0.42	2.08	4.01	3.18	1.80
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	18.09	5.49	6.71	4.27	2.44	1.02	1.83	2.64	2.85	0.41
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	26.01	9.36	8.21	5.93	2.97	1.37	2.28	3.88	3.42	4.79
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	17.19	5.61	8.35	7.22	1.62	0.75	2.24	4.36	2.87	2.62
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	20.55	6.12	9.18	7.87	2.19	0.44	1.31	3.28	3.28	2.40
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	30.14	11.82	13.59	7.09	3.55	0.59	2.07	7.98	1.48	3.84
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	28.77	7.95	10.01	5.25	1.75	1.43	1.43	7.47	3.34	3.66
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	28.60	5.36	9.38	4.69	1.56	0.45	3.35	6.93	3.13	2.01
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	42.75	8.27	12.50	10.89	2.82	1.61	2.62	5.04	4.84	4.44
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	30.37	7.80	11.71	6.45	4.07	1.53	2.88	7.63	4.07	2.21
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	22.70	8.42	7.89	4.17	3.19	1.15	2.93	4.52	2.75	2.31
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	36.11	10.41	16.34	7.60	4.37	1.77	3.54	6.45	2.91	2.39
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	28.35	7.86	16.57	5.81	3.24	1.37	1.88	3.24	1.71	2.56
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	35.96	8.52	11.07	7.08	3.32	1.00	1.44	6.42	2.66	2.99
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	25.46	5.49	10.15	4.99	3.83	1.16	1.91	6.57	3.24	2.75
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	20.62	5.31	12.25	5.92	1.63	1.02	2.25	5.51	1.43	1.43
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	34.66	9.28	13.82	8.46	3.09	1.03	1.44	4.13	4.75	2.68
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	31.82	8.19	11.64	6.23	3.92	0.92	2.19	7.84	4.61	2.88
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	35.69	7.67	9.51	6.34	1.50	1.00	2.00	3.34	2.33	2.50
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	37.47	10.58	9.04	8.38	3.75	1.10	1.98	3.97	3.75	2.42
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	25.83	8.73	7.75	10.33	2.34	1.23	1.72	7.50	2.21	3.44
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	40.20	8.59	9.08	5.02	1.78	0.97	1.46	6.81	2.59	3.73
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	38.81	9.62	13.15	6.74	1.92	1.28	1.28	5.77	3.85	4.81
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	33.73	10.04	7.77	7.11	1.80	1.23	2.18	6.16	4.55	2.08
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	33.22	10.12	6.49	4.90	2.06	0.79	0.95	3.01	1.11	1.11
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	35.88	8.51	10.34	5.47	3.04	0.91	0.91	2.13	1.22	1.52
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	31.47	8.36	6.48	4.50	2.82	1.05	1.25	4.91	2.61	2.61
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	29.20	8.12	6.15	4.61	2.20	0.44	1.54	3.95	1.76	0.66
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	33.39	8.42	12.06	6.17	1.68	1.12	1.96	5.89	2.52	3.37
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	32.41	8.70	3.80	3.52	0.93	1.39	1.39	3.15	2.31	1.48
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	30.48	4.28	4.55	3.48	1.34	1.34	1.60	2.67	0.53	0.53
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	37.95	7.04	3.67	2.75	1.07	0.46	1.99	1.84	0.61	0.77
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	29.02	8.29	3.63	3.63	1.55	1.17	1.94	4.66	1.55	0.91
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	43.64	8.67	5.15	4.61	1.63	0.27	1.08	2.44	1.36	2.44
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	46.09	11.25	4.79	3.50	1.47	1.84	3.50	3.50	1.66	2.03
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	39.04	9.21	4.82	5.04	1.32	1.54	1.54	4.17	1.54	1.10
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	129.92	18.84	3.97	2.98	0.99	1.98	3.97	0.99	0.99	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	45.38	10.68	5.14	3.83	1.71	3.56	1.71	3.43	1.85	2.37
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	41.56	11.70	4.24	4.64	1.61	2.02	2.22	3.23	1.01	1.61
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	78.54	24.65	5.34	1.78	0.51	5.59	2.80	1.78	0.76	1.27
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	19.51	5.97	21.10	7.17	5.97	0.00	2.19	3.38	2.79	0.40
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	11.86	4.31	11.71	5.24	2.77	0.15	3.24	3.39	1.08	0.92
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	22.91	5.52	13.91	4.50	6.55	0.82	3.27	5.32	5.52	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	30.04	4.07	22.84	6.26	5.95	0.94	1.88	5.01	6.88	3.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	23.45	4.52	20.63	2.83	5.65	0.57	3.11	7.63	6.22	1.13
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	26.75	4.61	19.37	5.53	3.23	0.00	2.31	6.46	5.53	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	22.27	0.00	12.37	7.42	0.00	0.00	4.95	2.47	4.95	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	22.82	3.48	18.57	5.03	3.48	0.77	1.55	8.12	4.25	1.93
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	33.69	3.21	12.84	6.42	3.21	0.00	1.60	12.84	11.23	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	19.13	0.00	8.69	8.69	0.00	0.00	0.00	6.96	6.96	1.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	32.22	4.56	14.00	5.53	1.63	0.65	1.63	6.18	3.91	2.93
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	24.71	2.47	15.65	5.35	4.94	0.82	0.82	4.94	4.12	1.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	43.32	0.00	23.33	10.00	0.00	0.00	3.33	6.66	6.66	3.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	32.72	3.64	16.78	4.75	4.75	1.12	1.12	5.87	2.52	3.08
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	30.07	5.23	16.34	5.23	2.94	0.33	2.29	7.19	5.88	3.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	29.36	5.03	13.42	10.90	1.68	0.00	1.68	2.52	5.03	1.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	39.44	4.13	17.18	6.68	7.00	0.64	0.95	8.59	6.68	1.91
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	36.68	6.11	18.00	9.85	5.43	0.34	1.36	8.15	4.42	5.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	22.97	2.09	14.62	8.35	2.09	0.00	0.00	8.35	2.09	8.35
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	38.37	4.58	29.21	8.02	7.45	0.00	1.15	13.74	6.30	1.72
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	25.45	2.66	17.17	7.10	4.14	0.30	2.07	9.77	5.92	5.62
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	38.97	5.08	25.41	20.33	3.39	0.00	0.00	22.02	8.47	8.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	46.39	10.77	25.27	7.87	7.04	0.83	1.24	11.60	7.04	12.01
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	45.57	5.98	21.86	8.74	4.83	0.46	2.53	8.28	4.37	4.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	36.88	0.00	10.54	5.27	10.54	0.00	0.00	31.61	10.54	26.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	40.36	4.23	17.30	9.23	2.69	0.77	1.54	14.99	7.69	4.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	35.20	8.48	20.21	11.41	3.91	0.98	1.30	13.69	9.78	12.71
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	51.50	8.69	21.40	15.38	0.67	0.00	2.01	31.44	14.05	23.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	35.83	4.24	24.66	15.41	6.93	0.39	2.70	12.71	3.47	4.62
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	47.24	6.50	18.83	10.27	4.79	0.68	2.74	14.38	6.85	9.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	67.09	4.97	19.88	12.42	0.00	0.00	0.00	27.33	4.97	19.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	40.11	6.13	26.42	16.51	6.61	0.00	3.77	13.68	4.72	2.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	51.90	4.83	26.55	12.07	6.03	0.60	1.21	19.92	7.85	7.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	70.20	6.10	21.36	13.73	3.05	0.51	1.53	17.29	10.68	13.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	51.45	3.59	29.12	14.76	4.79	0.00	2.79	9.97	7.58	4.79
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	34.53	2.96	22.20	14.80	4.44	0.00	0.99	16.28	3.45	8.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	30.69	3.54	16.53	18.89	9.44	1.18	1.18	16.53	8.26	12.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	33.26	9.34	35.01	16.34	4.08	0.00	1.75	15.75	11.09	7.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	28.53	4.83	16.24	13.61	3.95	0.00	0.88	14.04	3.07	4.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	41.54	4.24	20.34	8.48	8.48	0.85	0.00	11.02	4.24	5.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	39.40	7.16	13.73	2.98	4.78	1.19	1.79	10.15	4.18	3.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	27.66	8.25	15.04	5.34	2.91	0.49	1.94	7.76	5.82	3.40
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	19.40	6.85	3.42	0.00	0.00	3.42	1.14	0.00	1.14	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	33.27	12.89	1.66	1.25	1.25	3.33	0.83	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	32.61	10.12	6.75	5.62	1.12	2.25	1.12	3.37	2.25	3.37
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	21.57	8.56	3.81	3.49	2.85	5.39	1.27	0.32	0.63	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	19.63	8.35	5.01	4.18	1.25	3.34	1.25	0.42	0.84	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	41.66	14.51	3.83	1.97	3.37	3.02	2.09	1.04	0.58	0.00
Hep-2 cells mock treated, biol_rep2	11899-125E9	40.51	11.31	3.04	1.69	1.69	1.52	1.52	0.34	0.34	0.34
Hep-2 cells mock treated, biol_rep3	11900-125F1	36.63	8.65	4.55	1.82	2.73	1.82	1.14	0.23	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	36.40	13.23	2.95	2.30	2.95	2.84	2.73	0.55	0.66	0.55
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	42.12	12.04	3.22	0.86	2.79	2.36	1.29	0.64	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	39.61	11.19	2.58	2.37	1.94	1.51	0.86	0.22	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	39.60	12.20	2.99	1.74	2.37	2.86	1.62	0.75	0.62	0.25
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	35.85	8.58	2.06	1.54	2.06	1.20	1.89	0.34	0.17	0.51
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	40.69	8.97	0.64	0.96	1.28	0.64	2.24	0.32	0.00	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	36.94	7.28	5.04	3.36	0.00	1.12	1.12	2.24	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	31.59	5.19	2.60	4.33	0.87	0.87	1.30	0.43	0.87	0.43
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	31.73	7.93	0.00	0.00	2.64	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	32.80	15.52	1.41	2.12	0.71	2.82	0.71	2.12	0.35	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	34.87	5.09	3.63	1.45	0.73	0.00	2.18	1.45	0.00	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	29.20	9.09	3.15	3.50	1.05	1.05	0.87	0.87	0.35	1.05
Hepatocyte, donor1	11523-119I2	54.48	4.84	2.42	0.00	1.21	4.84	0.00	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	45.25	0.00	1.08	0.00	0.00	2.15	0.00	0.00	0.00	0.00
Hepatocyte, donor3	11684-122I1	49.08	5.52	3.07	0.00	1.23	2.45	0.00	0.00	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	25.45	4.57	1.31	0.65	5.22	0.65	2.61	0.65	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	23.07	3.32	2.80	1.22	1.05	0.70	0.70	0.35	0.00	0.17
Iris Pigment Epithelial Cells, donor1	11530-119I9	26.76	4.25	5.49	3.16	2.61	0.82	0.96	1.78	0.69	0.27
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	25.47	0.00	9.55	3.18	3.18	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	26.70	0.00	0.00	0.00	0.00	0.00	6.68	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	20.77	0.00	2.77	5.54	2.77	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	17.52	0.00	0.00	0.00	5.01	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	35.60	0.00	0.00	0.00	11.87	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	35.88	2.56	2.56	2.56	2.56	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	18.28	0.00	4.57	9.14	0.00	0.00	0.00	4.57	9.14	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	30.86	1.62	0.00	6.50	1.62	0.00	1.62	1.62	1.62	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	36.68	1.67	10.00	3.33	3.33	0.00	3.33	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	21.78	0.00	10.89	0.00	0.00	0.00	0.00	0.00	0.00	3.63
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	38.38	3.97	2.65	2.65	1.32	0.00	1.32	2.65	1.32	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	16.63	0.00	7.76	2.22	0.00	0.00	0.00	2.22	1.11	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	31.43	0.00	0.00	0.00	0.00	0.00	0.00	5.24	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	22.68	1.89	5.04	5.04	3.78	0.00	0.63	1.89	0.00	0.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	21.65	3.09	15.47	7.73	6.19	0.00	0.00	0.00	3.09	1.55
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	31.66	1.29	8.40	6.46	3.88	0.65	0.65	1.94	2.58	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	30.59	1.61	3.22	0.00	1.61	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	35.84	0.00	11.95	0.00	0.00	0.00	0.00	0.00	11.95	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	22.00	3.26	6.52	4.07	0.81	0.00	0.81	5.70	1.63	0.81
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	15.53	0.42	6.30	2.94	1.68	0.42	0.00	0.84	1.26	1.26
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	71.86	0.00	0.00	0.00	0.00	0.00	0.00	14.37	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	24.91	0.00	8.84	4.82	3.21	0.80	0.00	0.80	0.00	0.80
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	33.24	1.85	9.23	1.85	4.62	0.00	0.00	0.00	0.92	0.92
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	45.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	22.19	0.94	5.19	5.66	3.78	0.00	0.94	0.94	0.94	0.94
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	26.30	0.91	4.53	3.63	0.00	0.00	0.00	1.81	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	14.74	0.00	14.74	0.00	0.00	0.00	0.00	14.74	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	33.36	4.30	2.15	4.30	2.15	1.08	1.08	0.00	3.23	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	35.57	1.27	7.62	1.27	2.54	1.27	1.27	1.27	3.81	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	0.00	16.43	16.43	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	25.51	3.19	6.38	4.46	1.28	0.00	0.64	0.64	1.28	0.64
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	30.99	3.65	1.82	3.65	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	47.41	0.00	0.00	0.00	0.00	0.00	0.00	15.80	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	34.99	1.43	4.28	4.28	1.43	0.00	0.00	0.71	0.71	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	26.55	0.00	13.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	62.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	27.78	1.54	3.70	0.93	3.09	0.62	0.93	0.93	0.31	0.31
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	52.68	5.27	3.51	1.76	1.76	0.00	1.76	1.76	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	44.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	3.14	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	26.42	3.48	6.26	1.39	2.78	0.00	1.39	0.70	1.39	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	39.84	2.21	2.21	11.07	0.00	0.00	0.00	2.21	0.00	2.21
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	48.63	0.00	9.73	0.00	3.24	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	22.67	2.62	5.23	5.23	3.49	0.00	0.00	0.87	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	53.99	0.00	9.00	4.50	2.25	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	45.30	3.48	6.97	0.00	0.00	0.00	0.00	3.48	3.48	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	20.27	0.00	6.40	3.20	1.07	0.00	0.00	2.13	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	40.18	1.39	6.93	0.00	5.54	0.00	1.39	0.00	1.39	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	48.44	0.00	11.40	2.85	2.85	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	24.85	0.00	9.20	6.44	3.68	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	24.20	0.00	9.08	6.05	3.03	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	43.46	0.00	12.42	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	21.15	0.00	3.17	3.17	2.11	0.00	0.00	0.00	0.00	1.06
Keratinocyte - epidermal, donor1	11272-116H3	29.05	6.45	3.59	1.63	2.28	1.63	2.37	0.33	0.24	0.33
Keratinocyte - epidermal, donor2	11349-117G8	14.06	5.86	0.00	2.34	2.34	0.00	0.59	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	36.63	6.82	2.37	2.56	0.95	0.76	0.95	0.09	0.28	0.09
Keratinocyte - oral, donor1	11251-116E9	20.55	11.47	6.36	3.97	2.38	0.68	1.59	0.57	0.34	0.23
Keratocytes, donor1	11527-119I6	22.35	3.44	2.41	5.50	1.38	0.69	0.00	0.00	0.00	0.00
Keratocytes, donor2	11607-120I5	53.90	11.72	5.86	4.69	2.34	1.17	0.00	2.34	0.00	0.00
Keratocytes, donor3	11688-122I5	23.91	5.73	4.35	3.16	0.40	0.59	0.79	0.00	0.59	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	120.89	35.17	4.40	6.59	2.20	6.59	4.40	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	30.20	8.63	3.24	1.08	3.24	1.08	1.08	1.08	1.08	1.08
Lens Epithelial Cells, donor2	11609-120I7	36.56	7.04	11.19	3.34	4.04	1.85	1.15	3.81	2.42	3.58
Lens Epithelial Cells, donor3	11690-122I7	31.69	11.60	4.94	2.22	1.72	1.11	1.51	2.62	1.41	1.11
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	21.23	5.22	2.02	1.42	1.42	0.59	1.07	0.36	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	10.33	5.02	1.40	2.23	0.56	0.84	1.12	0.00	0.84	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	15.43	3.78	1.57	1.57	2.05	0.31	1.26	0.63	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	11.29	2.15	1.61	3.76	1.08	0.54	1.08	0.00	0.54	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	11.66	4.41	2.21	1.89	1.58	0.32	0.63	0.00	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	16.17	3.99	2.48	1.94	1.73	1.40	0.65	0.22	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	10.26	2.46	1.64	1.23	1.64	0.82	0.82	0.00	0.41	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	10.87	4.05	3.03	1.77	0.76	1.52	1.01	0.25	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	14.92	4.36	1.27	1.41	1.55	0.70	1.27	0.14	0.14	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	11.07	1.58	0.40	0.79	0.40	0.40	0.79	0.79	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	15.70	6.40	2.71	1.94	1.16	0.78	0.78	0.39	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	11.48	3.15	1.30	0.93	1.30	0.56	0.19	0.56	0.00	0.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	12.89	4.53	3.83	0.70	1.05	0.35	0.35	0.00	0.35	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	16.22	6.44	2.62	1.91	2.15	0.48	1.19	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	13.73	3.16	1.51	0.96	1.65	0.41	0.82	0.27	0.00	0.14
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	16.01	5.24	0.92	1.54	1.54	0.62	0.31	0.00	0.31	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	12.16	3.12	1.25	0.94	0.62	0.62	0.62	0.00	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	17.02	4.39	2.01	1.83	1.83	0.55	0.18	0.37	0.18	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	11.85	4.61	1.97	1.65	1.65	0.33	0.99	0.33	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	9.66	3.51	1.46	1.76	0.59	0.00	0.88	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	15.43	1.99	1.00	1.24	1.74	0.50	0.50	0.25	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	19.40	4.36	1.94	1.94	1.45	0.48	0.48	0.48	0.48	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	9.69	3.23	1.35	2.69	1.89	0.27	0.81	0.54	0.27	0.54
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	15.89	3.94	1.36	0.76	2.42	1.06	0.15	0.45	0.30	0.15
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	12.96	3.11	1.56	2.07	0.52	1.04	2.07	0.52	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	13.82	4.40	1.88	3.14	0.63	1.26	0.21	0.21	0.21	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	16.99	4.36	2.11	2.26	1.65	0.75	0.45	0.60	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	9.63	4.82	1.38	2.75	1.38	0.00	0.00	0.69	0.69	0.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	11.67	5.27	1.88	2.26	0.94	0.19	0.75	0.38	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	17.49	3.18	1.91	0.95	1.80	1.06	0.42	0.21	0.21	0.11
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	14.05	4.85	0.97	2.42	1.94	0.48	0.48	0.00	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	7.61	3.64	0.99	1.98	1.65	0.66	0.33	0.33	0.33	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	15.49	5.20	0.99	2.60	1.24	0.74	0.74	0.37	0.50	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	20.36	5.18	2.96	1.11	2.22	0.00	1.11	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	7.91	3.95	2.47	1.24	1.24	0.25	0.25	0.00	0.49	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	13.75	4.54	0.82	1.24	2.20	0.69	1.10	0.14	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	14.80	1.29	1.93	1.61	0.64	0.32	0.32	0.32	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	8.22	3.96	3.35	3.04	1.83	0.91	0.91	0.00	0.30	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	18.48	5.32	1.12	2.10	2.24	0.84	0.42	0.42	0.14	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	13.87	2.49	1.42	1.42	1.07	0.71	0.00	0.00	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	8.24	2.91	0.48	3.39	2.42	0.97	0.00	0.48	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	15.09	4.51	2.02	1.40	1.40	0.93	0.16	0.00	0.16	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	18.62	4.66	1.79	1.79	0.36	0.36	0.00	1.07	0.00	0.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	13.72	4.57	2.94	2.61	2.29	0.00	0.65	0.65	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	12.48	2.83	2.35	0.71	0.94	0.47	1.18	0.24	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	20.54	5.20	1.61	1.11	1.86	0.62	0.99	0.50	0.25	0.12
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	10.50	3.59	1.28	1.54	0.51	0.00	0.51	0.77	0.26	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	16.71	2.69	1.19	3.88	1.49	2.09	1.19	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	4.53	9.06	2.27	0.00	2.27	0.00	2.27	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	29.15	8.44	2.30	0.77	0.00	0.00	0.77	0.00	0.00	0.77
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	20.04	5.94	2.23	2.23	0.00	0.00	0.74	0.00	0.00	0.74
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	18.19	6.77	2.54	1.27	0.42	0.42	1.69	0.00	0.42	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	29.54	9.85	1.41	2.11	0.70	1.41	0.70	0.70	0.70	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	26.15	7.47	2.80	0.93	0.00	2.80	1.87	0.00	0.93	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	17.00	6.70	4.12	3.09	1.55	0.52	0.52	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	30.93	7.14	3.57	1.19	1.19	0.00	1.19	0.00	1.19	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	11.08	8.82	4.98	2.49	0.90	0.45	2.94	0.45	0.23	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	24.14	11.05	2.91	1.16	0.29	0.87	3.20	0.29	0.00	0.29
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	31.06	7.65	5.85	2.25	0.90	0.90	2.70	0.00	0.45	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	16.53	10.57	3.93	1.90	0.54	0.54	3.12	0.27	0.41	0.14
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	29.27	6.68	1.03	0.00	1.03	0.51	3.08	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	28.23	14.11	4.23	1.06	1.06	0.71	1.06	0.71	0.00	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	14.66	9.33	3.33	3.33	0.00	1.33	1.33	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	19.36	8.66	2.55	2.55	0.00	0.00	2.55	0.51	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	25.35	7.20	4.54	2.67	0.53	0.53	3.20	0.27	0.27	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	23.05	12.28	3.40	0.57	0.38	1.70	2.27	0.19	0.38	0.19
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	19.02	9.82	3.68	4.29	1.23	1.23	1.84	0.00	0.00	1.23
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	28.54	9.79	4.08	2.45	0.82	0.82	2.45	2.45	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	22.70	12.70	5.21	1.46	0.62	0.42	2.29	1.67	0.21	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	24.10	10.09	4.20	1.96	1.68	0.56	1.40	0.56	0.56	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	30.91	5.15	2.06	1.03	0.00	0.00	4.12	0.00	1.03	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	24.97	11.90	4.06	0.87	1.16	1.74	1.45	0.29	0.58	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	23.91	8.67	2.69	2.09	1.20	1.20	1.20	0.90	0.30	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	36.51	13.83	2.21	3.32	1.66	0.55	1.66	0.00	0.00	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	28.99	9.90	7.07	1.06	0.00	0.71	1.41	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	23.23	8.85	4.79	1.48	0.37	1.11	3.32	1.48	0.37	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	28.78	6.91	4.61	0.00	0.00	0.00	3.45	1.15	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	22.26	9.59	3.07	1.15	0.77	0.77	1.54	0.38	0.38	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	16.42	7.36	1.70	2.83	1.70	0.57	1.70	0.57	0.00	0.57
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	26.25	15.59	4.10	2.46	0.00	0.82	2.46	1.64	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	21.69	9.49	4.97	0.45	0.45	0.90	2.71	0.45	0.90	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	22.26	9.34	3.59	2.87	0.00	1.44	1.44	0.72	0.72	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	41.83	8.96	5.98	2.24	0.75	1.49	2.24	0.75	0.75	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	20.44	8.92	4.83	1.49	0.74	1.11	1.86	1.11	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	16.80	8.61	3.02	1.29	0.86	0.43	3.02	0.43	0.43	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	29.97	5.99	7.71	3.43	0.00	0.00	0.86	0.00	0.86	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	28.32	7.66	4.00	2.00	2.33	2.00	1.67	1.00	0.00	0.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	25.94	7.84	3.62	3.02	0.60	0.60	1.21	0.00	0.00	0.60
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	19.91	4.98	4.27	0.71	0.00	0.71	2.84	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	25.09	13.06	2.41	2.75	0.69	1.37	3.09	0.34	0.34	0.34
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	21.47	6.44	3.76	2.15	1.61	0.00	0.54	0.54	0.54	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	32.99	12.79	2.02	2.02	0.67	1.35	3.37	0.67	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	24.45	11.48	2.59	0.74	0.37	0.74	0.74	0.74	0.37	0.37
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	22.10	6.98	3.49	0.00	1.16	2.33	3.49	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	28.56	6.35	6.35	0.00	1.06	0.00	3.17	1.06	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	24.41	11.60	2.80	2.00	1.60	0.40	2.40	0.00	0.80	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	21.08	5.81	4.36	2.18	1.45	0.73	5.09	0.00	0.00	0.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	27.59	6.90	2.30	3.07	0.00	0.77	1.53	0.77	0.00	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	25.16	8.88	0.99	3.95	0.00	0.00	2.96	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	17.88	1.88	1.88	0.94	0.94	2.82	2.82	0.00	0.94	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	29.67	13.58	4.53	3.02	1.01	0.50	2.51	0.00	1.01	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	22.08	11.27	2.25	3.60	1.35	0.45	3.60	0.90	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	17.21	6.88	5.16	3.44	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	32.96	13.36	2.67	0.45	0.45	0.45	1.78	0.45	0.45	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	29.33	12.51	3.52	2.35	0.39	0.00	2.74	0.78	0.39	0.39
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	15.83	7.92	3.96	1.98	0.66	0.00	1.98	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	22.31	11.94	3.63	2.59	1.04	1.04	3.63	0.00	0.52	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	25.38	11.38	5.25	0.88	0.88	0.44	1.31	0.00	0.44	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	22.36	6.71	2.80	2.80	0.56	0.56	2.24	1.68	0.56	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	27.38	9.72	3.97	0.88	0.44	0.88	1.32	0.44	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	29.70	11.57	2.31	2.31	1.16	1.54	3.47	0.39	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	18.23	9.11	4.05	0.51	0.00	0.51	1.52	0.51	0.00	0.51
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	26.91	11.53	4.33	1.92	0.00	0.48	2.40	0.96	1.44	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	29.02	10.34	3.18	1.19	0.00	2.39	2.78	0.80	0.40	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	16.41	4.86	3.65	2.43	1.22	1.22	3.04	0.00	0.00	0.61
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	32.51	5.53	4.15	3.46	0.69	0.00	2.77	2.77	0.69	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	27.74	11.40	3.04	2.66	0.76	1.52	2.66	0.76	0.76	0.38
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	18.59	7.23	2.58	1.55	0.52	1.03	1.03	0.00	0.00	0.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	20.56	8.47	4.23	8.47	0.00	1.21	1.81	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	23.77	9.19	4.12	3.17	2.54	0.00	3.17	1.58	0.95	0.63
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	32.52	4.80	5.86	0.53	1.07	0.53	1.60	2.67	1.07	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	14.37	9.77	8.62	1.72	0.57	0.57	0.00	0.57	0.57	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	26.23	8.74	5.14	0.51	0.51	0.51	2.57	0.51	0.51	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	19.10	8.49	4.24	1.41	0.71	0.71	2.12	0.71	0.71	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	20.43	5.67	8.51	2.27	0.57	0.57	1.70	1.13	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	27.87	10.82	5.82	2.08	2.08	3.74	3.74	1.25	0.83	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	19.58	5.48	4.70	3.13	2.35	0.00	1.57	1.57	2.35	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	23.80	8.35	6.68	5.01	0.42	0.42	2.09	0.42	0.42	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	39.49	9.76	2.32	0.93	0.00	1.86	3.25	0.00	1.39	2.32
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	26.09	11.37	5.35	1.34	0.00	2.68	0.67	1.34	1.34	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	31.54	6.42	6.95	4.28	0.00	1.60	2.67	0.00	0.53	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	25.86	10.10	6.47	3.64	2.02	0.81	3.23	1.21	0.00	0.40
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	28.45	11.01	9.18	2.75	0.92	0.92	0.92	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	20.45	0.89	12.45	2.67	1.78	0.89	2.67	1.78	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	37.04	11.97	5.70	3.42	3.42	0.00	3.99	1.14	1.14	0.57
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	32.21	14.57	10.74	5.37	0.00	0.77	2.30	0.77	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	31.74	7.66	15.32	3.83	0.00	0.00	1.09	0.00	2.19	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	31.18	12.03	5.79	2.67	0.45	1.78	2.67	1.34	0.45	0.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	16.38	8.58	7.28	3.90	2.08	1.30	3.90	1.82	0.78	0.52
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	33.82	7.29	12.60	7.96	0.00	1.33	1.33	3.32	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	47.81	18.71	6.24	2.08	4.16	0.00	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	12.76	2.73	1.82	1.37	1.14	0.23	0.23	0.00	0.00	0.00
Macrophage - monocyte derived, donor2	11313-117C8	8.26	2.39	0.92	0.73	0.73	0.00	0.55	0.00	0.18	0.00
Macrophage - monocyte derived, donor3	11389-118C3	22.68	6.29	1.05	2.49	0.39	0.39	1.57	0.00	0.13	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	22.30	7.97	4.78	5.31	3.19	1.06	1.06	0.00	1.59	0.00
Mallassez-derived cells, donor2	11929-125I3	33.59	8.56	5.07	3.96	1.27	0.79	2.85	0.95	0.32	0.79
Mallassez-derived cells, donor3	11930-125I4	26.27	7.78	3.75	3.75	1.81	1.11	2.50	0.28	0.42	0.56
Mammary Epithelial Cell, donor1	11273-116H4	38.96	9.47	4.78	5.88	3.39	1.59	2.59	0.60	0.30	0.50
Mammary Epithelial Cell, donor2	11350-117G9	31.27	4.92	2.32	3.47	2.32	0.58	1.16	0.58	0.29	0.00
Mammary Epithelial Cell, donor3	11422-118F9	24.94	6.24	3.49	4.74	1.25	0.75	1.75	0.25	0.00	0.50
Mast cell - stimulated, donor1	11487-119E2	41.35	6.78	3.39	1.36	4.07	2.71	2.03	3.39	0.00	0.68
Mast cell, donor1	11563-120D6	39.26	13.95	5.52	2.05	1.62	0.54	2.05	0.43	0.00	0.11
Mast cell, donor2	11565-120D8	25.85	16.64	8.32	3.57	3.27	2.08	1.49	0.30	1.78	0.30
Mast cell, donor3	11566-120D9	23.86	15.76	11.26	3.38	5.18	2.03	0.68	0.23	0.23	0.23
Mast cell, donor4	11567-120E1	27.66	17.73	5.14	4.08	2.84	1.77	1.24	0.00	0.35	0.18
Mast cell, expanded and stimulated, donor5	11940-126A5	30.50	17.08	4.77	0.89	2.77	1.66	2.55	0.44	0.22	0.11
Mast cell, expanded and stimulated, donor8	11942-126A7	13.42	4.67	7.00	3.50	1.75	1.17	1.75	1.75	1.17	0.00
Mast cell, expanded, donor5	11939-126A4	19.85	11.82	4.59	2.75	1.49	1.03	2.06	0.23	0.46	0.00
Mast cell, expanded, donor8	11941-126A6	34.65	17.07	5.86	2.01	2.68	1.34	2.85	0.17	0.17	0.17
Melanocyte - dark, donor1	11502-119F8	27.06	8.86	1.59	0.80	2.09	2.79	1.49	0.80	0.20	0.20
Melanocyte - dark, donor2	11582-120F7	31.49	7.61	2.42	5.88	1.38	1.38	0.69	0.00	1.04	0.35
Melanocyte - dark, donor3	11663-122F7	26.22	5.22	3.48	1.23	2.03	0.43	1.09	0.29	0.07	0.00
Melanocyte - light, donor1	11274-116H5	14.81	3.76	1.65	1.18	1.41	0.47	0.94	0.00	0.00	0.00
Melanocyte - light, donor2	11351-117H1	8.87	5.46	2.05	0.68	0.68	0.68	1.36	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	21.68	6.07	3.47	3.47	1.73	0.00	2.60	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	23.43	5.94	2.39	1.04	1.87	0.83	1.15	0.21	0.52	0.10
Melanocyte, donor2 (MC+2)	12739-135I3	15.06	7.53	2.69	1.34	0.81	0.54	0.81	0.54	0.27	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	39.11	16.34	5.62	2.41	2.95	1.34	4.29	0.80	0.80	0.27
Meningeal Cells, donor1	11493-119E8	51.73	6.95	6.45	2.73	3.97	2.85	0.87	1.36	1.49	0.50
Meningeal Cells, donor2	11573-120E7	84.51	6.16	7.04	6.16	1.76	0.88	0.44	1.76	1.32	0.00
Meningeal Cells, donor3	11654-122E7	31.95	8.64	7.66	6.68	3.83	2.45	1.30	3.42	1.79	1.63
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	49.33	15.97	14.54	11.12	4.28	8.55	2.00	12.83	5.99	7.41
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	13.69	8.15	3.02	1.81	2.42	1.61	1.71	1.11	0.50	0.81
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	15.77	6.57	1.31	1.31	0.00	5.26	1.31	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	34.01	3.92	6.54	1.31	3.92	3.92	2.62	1.31	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	30.14	10.76	4.31	3.59	1.44	0.00	2.15	3.59	0.72	1.44
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	27.95	13.34	6.56	2.33	2.12	2.75	1.06	1.27	0.85	1.06
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	35.19	17.59	4.52	2.01	1.01	1.51	2.01	1.01	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	36.04	13.19	8.13	6.59	3.30	6.81	1.98	13.62	7.03	5.05
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	50.41	15.34	5.84	7.31	1.46	3.65	1.46	5.84	1.46	2.92
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	45.63	13.30	4.71	5.93	3.27	7.77	3.68	15.55	7.77	6.34
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	23.82	9.70	10.94	5.96	1.94	3.46	0.42	5.40	2.22	0.69
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	23.05	8.92	1.12	2.23	0.37	3.35	1.49	1.12	0.37	0.37
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	26.31	9.34	4.87	4.21	1.18	1.58	1.32	1.32	0.92	0.79
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	19.58	9.20	1.78	2.97	0.89	2.67	0.89	0.89	0.59	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	18.68	14.01	2.34	2.34	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	30.10	10.25	4.48	3.84	1.28	1.92	0.00	0.00	1.92	0.64
Mesenchymal stem cells - adipose, donor0	11217-116B2	23.04	11.70	6.38	8.15	3.19	4.25	4.61	3.19	2.84	0.71
Mesenchymal stem cells - hepatic, donor0	11218-116B3	18.45	7.19	5.00	4.07	1.56	3.13	0.63	0.63	0.31	0.94
Mesenchymal stem cells - umbilical, donor0	11214-116A8	32.66	8.71	5.08	5.81	0.73	1.45	2.90	0.73	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	26.25	12.20	1.86	1.59	2.65	1.06	3.18	1.06	0.53	0.53
Mesothelial Cells, donor2	12156-128G5	30.03	15.51	3.50	0.50	1.50	3.00	1.00	0.50	1.00	0.50
Mesothelial Cells, donor3	11402-118D7	30.28	14.74	2.67	3.04	1.23	1.37	2.31	0.72	0.65	0.58
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	68.87	14.85	1.35	0.00	0.00	2.70	6.75	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	27.34	6.65	0.25	2.46	0.49	0.49	0.49	0.00	0.00	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	15.61	7.07	0.88	1.18	1.18	1.18	0.59	0.00	0.88	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	24.20	6.91	0.00	3.46	0.00	3.46	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	11.16	3.10	2.17	2.17	0.93	0.31	0.31	0.31	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	11.41	4.56	0.62	1.04	0.62	0.00	1.04	0.41	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	23.16	4.63	0.00	0.00	2.32	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	17.27	4.75	1.25	3.00	0.50	0.25	1.75	0.25	0.50	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	18.15	5.59	1.40	2.79	0.47	0.00	3.72	0.00	0.47	0.93
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	14.43	4.88	0.61	2.03	0.41	0.20	0.81	0.00	0.20	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	8.71	1.98	1.58	0.00	1.19	0.00	1.98	0.00	0.40	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	42.76	0.00	0.00	0.00	0.00	0.00	8.55	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	7.96	1.77	0.00	2.65	0.88	0.00	0.88	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	10.64	4.18	1.90	1.90	0.38	0.00	1.14	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	18.42	1.32	0.00	1.32	0.00	0.00	1.32	0.00	1.32	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	12.10	2.97	0.42	0.85	0.21	0.00	0.85	0.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	18.42	3.68	1.84	0.00	0.92	0.00	0.92	0.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	14.60	4.17	0.30	1.49	0.89	0.00	0.89	0.30	0.00	0.30
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	23.47	8.38	0.00	1.68	0.00	0.00	5.03	0.00	1.68	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	67.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	9.79	3.26	2.01	1.25	0.50	0.25	1.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	9.74	3.33	0.71	0.71	0.48	0.00	0.24	0.00	0.24	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	6.08	3.87	1.66	1.11	0.55	0.00	0.55	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	8.75	3.22	0.23	0.92	0.46	0.23	0.23	0.46	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	5.89	4.00	0.63	0.84	0.21	0.21	1.47	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	14.27	3.06	0.61	1.02	0.20	0.20	0.61	0.00	0.20	0.41
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	6.87	2.57	0.00	0.86	0.64	0.00	0.64	0.00	0.64	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	12.67	3.33	1.11	0.67	0.22	0.00	0.00	0.22	0.44	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	10.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	9.86	1.97	0.22	0.22	0.66	0.22	0.88	0.22	0.22	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	12.17	4.06	0.51	1.52	0.51	0.00	2.03	0.00	0.51	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	14.91	3.31	0.00	0.00	0.00	0.00	1.66	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	8.43	4.08	0.54	1.63	0.00	0.00	0.27	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	8.53	2.06	0.59	0.29	0.29	0.00	0.88	0.29	0.29	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	9.81	7.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	9.61	1.44	0.00	0.96	0.00	0.00	0.96	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	9.61	1.60	0.00	0.40	0.00	0.00	0.40	0.80	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	13.71	2.74	1.37	0.00	0.00	0.00	1.37	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	6.51	1.50	0.50	1.00	0.00	0.50	0.50	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	42.81	2.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	4.38	1.75	0.44	1.31	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	19.87	1.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	23.05	3.20	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	6.94	1.49	0.99	1.49	0.74	0.00	0.50	0.00	0.25	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	11.13	2.09	0.70	1.39	0.70	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	22.10	8.84	0.00	2.21	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	7.86	1.03	0.34	1.37	0.00	0.00	0.34	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	14.44	2.63	0.44	1.31	0.00	0.00	1.31	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	20.60	1.42	0.71	1.78	0.00	0.00	0.00	0.00	0.36	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	9.54	1.96	1.40	0.84	0.28	0.28	0.56	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	8.31	1.66	1.25	0.42	0.42	0.00	0.42	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	37.30	4.08	0.58	1.17	0.00	0.00	0.58	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	12.07	2.11	0.60	1.51	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	10.02	1.67	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	50.53	7.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	15.70	2.77	2.77	2.77	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	12.52	0.00	0.00	1.71	0.00	0.00	1.71	0.57	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	14.23	2.21	0.41	1.24	0.00	0.00	0.83	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	9.07	0.78	0.52	1.04	0.00	0.00	0.52	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	14.59	1.29	1.29	0.00	0.00	0.00	0.43	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	35.57	3.18	0.00	0.00	0.64	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	13.88	2.14	0.80	0.27	0.27	0.27	0.80	0.00	0.00	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	16.16	2.99	2.10	1.20	0.30	0.00	0.30	0.00	0.30	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	13.56	1.98	1.13	1.13	0.00	0.00	0.42	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	11.47	1.91	0.00	1.27	0.00	0.00	0.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	15.92	1.33	1.33	1.11	0.88	0.00	1.11	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	15.93	3.03	0.38	1.14	0.00	0.00	1.52	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	13.35	2.27	1.14	1.14	0.85	0.00	1.14	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	11.80	1.47	1.23	1.72	0.00	0.00	0.49	0.00	0.00	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	23.46	1.96	0.00	0.65	0.00	0.00	1.30	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	12.94	2.65	2.06	0.88	0.59	0.00	0.88	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	15.86	1.73	0.86	2.59	0.29	0.58	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	22.26	0.82	1.24	2.47	0.41	0.00	0.82	0.00	0.41	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	15.19	2.98	0.89	0.89	0.60	0.00	0.89	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	18.83	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	14.26	0.00	1.78	3.56	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	26.94	3.94	1.64	1.97	0.33	0.33	0.99	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	10.52	2.10	1.05	0.00	0.00	0.00	2.10	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	14.83	3.16	0.79	0.79	0.00	0.00	0.99	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	7.45	3.73	1.86	1.86	0.00	0.93	1.86	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	25.54	3.38	1.50	1.13	0.38	0.00	0.38	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	16.25	4.79	1.86	1.60	0.00	0.00	1.86	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	10.41	3.51	0.45	0.90	0.23	0.23	1.58	0.11	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	15.47	4.42	0.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	30.78	4.40	0.73	1.10	0.00	0.00	1.10	0.37	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	20.22	1.56	0.00	4.67	0.00	1.56	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	16.03	1.60	2.14	0.53	1.07	0.00	0.53	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	30.91	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	28.28	4.04	1.01	2.02	1.01	0.00	1.01	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	26.98	5.90	0.84	1.26	0.42	0.42	2.11	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	4.09	0.00	1.36	1.36	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	3.81	0.00	0.00	0.00	0.64	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	5.67	0.00	0.00	0.81	0.81	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	16.61	1.51	1.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	5.71	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	9.79	0.00	3.26	0.00	0.00	0.00	0.00	0.00	0.00	3.26
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	0.00	4.75	0.00	0.00	4.75	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	50.20	0.00	0.00	12.55	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	20.47	10.56	3.88	2.80	1.51	3.88	1.72	1.94	1.08	1.08
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	50.69	20.90	4.70	3.14	1.57	4.70	1.57	0.00	0.00	0.52
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	60.74	12.01	6.01	2.67	0.67	4.00	2.67	4.67	1.33	1.33
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	94.33	15.44	5.43	3.34	0.42	3.76	2.50	6.68	3.34	0.83
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	194.13	23.01	5.13	8.94	4.75	5.51	4.56	3.42	0.76	2.66
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	328.75	38.30	20.75	14.36	1.60	9.58	4.79	1.60	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	57.80	6.12	1.36	4.08	0.68	2.04	4.08	3.40	1.36	5.44
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	27.56	18.38	9.19	12.86	1.84	1.84	1.84	1.84	3.68	1.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	40.60	8.37	2.09	3.35	0.84	1.26	1.26	0.84	0.84	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	85.54	14.18	4.18	6.97	1.86	3.95	2.09	2.32	3.95	3.02
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	68.37	16.21	1.62	2.16	1.35	2.70	2.97	1.62	1.89	1.08
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	83.46	14.93	5.05	3.36	2.73	4.84	1.89	3.78	0.42	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	33.40	11.13	11.13	11.13	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	34.25	18.37	2.48	2.98	0.99	6.45	3.47	2.48	0.00	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	67.40	15.97	1.62	2.98	0.81	2.71	2.44	1.08	0.54	0.54
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	41.48	9.52	2.49	2.27	1.59	3.40	1.13	1.36	0.91	0.68
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	97.82	11.92	2.29	1.80	0.49	1.96	0.33	0.82	0.98	0.65
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	58.50	10.21	4.01	1.64	2.73	2.92	2.19	0.91	1.09	0.18
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	36.07	13.79	3.71	2.65	1.06	2.65	2.65	1.59	2.12	1.59
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	32.42	8.40	3.00	1.80	1.20	1.80	3.00	3.00	0.60	1.20
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	68.26	27.24	2.30	3.61	3.61	5.58	2.30	0.00	0.33	0.33
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	57.41	11.06	1.30	2.44	1.14	1.46	0.49	0.81	0.98	0.49
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	97.01	20.64	4.94	2.65	2.47	7.58	2.65	1.06	0.88	0.35
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	29.54	13.36	0.00	2.11	0.00	5.63	2.81	2.81	0.70	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	42.75	12.87	1.38	0.92	0.92	2.76	1.84	0.46	1.38	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	56.24	12.85	1.93	1.93	0.96	3.21	2.57	1.61	1.29	1.29
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	79.67	27.94	1.38	2.07	3.10	2.76	1.38	0.69	0.34	1.03
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	58.15	25.28	0.00	15.17	17.70	12.64	2.53	2.53	5.06	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	81.09	16.26	3.12	2.45	2.23	5.12	0.45	1.34	0.67	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	38.53	13.97	3.39	1.69	0.85	1.69	1.27	2.54	1.27	1.27
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	63.85	11.16	3.80	2.37	1.42	2.37	0.47	0.47	0.24	0.47
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	54.94	11.59	2.15	3.43	1.72	2.58	0.86	2.58	2.15	0.86
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	27.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	66.31	16.66	1.00	2.33	0.67	3.33	2.00	1.67	3.00	1.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	92.43	13.98	2.71	1.35	4.06	7.21	0.45	1.80	0.90	1.35
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	26.59	8.33	3.17	0.79	0.79	1.98	1.59	0.79	1.59	1.19
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	29.72	11.14	0.00	0.93	0.93	2.79	0.93	1.86	1.86	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	66.59	15.89	2.27	4.16	1.51	2.65	1.14	2.65	0.76	1.14
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	51.16	12.38	0.98	2.28	0.65	2.28	0.98	0.98	1.30	1.30
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	72.34	19.61	3.05	2.18	0.44	5.67	0.44	4.36	1.74	1.31
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	99.05	14.93	5.43	2.71	0.45	3.62	2.71	1.81	0.90	1.36
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	27.34	13.23	0.00	1.76	0.00	3.53	4.41	1.76	1.76	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	33.91	16.62	6.65	0.00	1.99	3.32	1.33	2.66	1.33	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	47.12	19.35	2.48	2.98	0.00	2.98	0.50	0.99	1.98	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	61.25	16.08	0.77	0.38	1.91	3.83	1.15	2.30	0.00	1.15
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	46.58	12.10	2.12	3.02	1.21	2.12	1.51	2.12	0.30	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	58.35	12.82	2.21	1.99	2.21	3.32	1.77	0.88	0.44	0.44
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	27.78	8.13	2.03	1.36	0.00	4.74	1.36	1.36	0.68	2.71
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	20.44	25.55	0.00	5.11	5.11	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	44.51	12.19	4.27	1.83	0.00	4.27	0.61	2.44	3.05	1.83
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	61.69	13.22	1.26	1.89	1.26	3.46	2.20	1.89	1.26	1.57
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	96.55	20.28	2.42	1.51	1.21	3.93	1.21	2.12	3.03	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	28.48	15.03	0.79	1.58	0.00	2.37	1.58	3.96	0.79	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	69.15	21.54	0.00	5.67	4.53	5.67	2.27	2.27	0.00	2.27
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	25.29	10.12	5.06	5.06	0.00	0.00	0.00	0.00	5.06	0.00
Myoblast, donor1	11241-116D8	15.90	7.83	3.60	2.24	2.73	1.86	0.87	1.12	0.75	0.75
Myoblast, donor2	11322-117D8	40.66	15.92	7.10	5.75	4.41	8.06	2.30	7.10	1.73	3.64
Myoblast, donor3	11398-118D3	40.02	9.75	2.19	2.86	2.52	1.51	3.20	0.84	0.34	0.84
NK T cell leukemia cell line:KHYG-1	10777-110G3	44.22	6.57	0.58	0.58	2.77	0.00	1.17	0.44	0.00	0.00
Natural Killer Cells, donor1	11230-116C6	29.52	15.07	3.38	0.92	4.61	2.15	1.23	0.62	0.00	0.00
Natural Killer Cells, donor2	11311-117C6	42.52	12.97	1.81	0.90	3.62	1.81	1.81	0.90	0.00	0.90
Natural Killer Cells, donor3	11387-118C1	45.65	13.44	1.66	0.92	3.68	0.55	2.58	0.55	0.18	0.92
Neural stem cells, donor1	11275-116H6	45.73	8.35	17.42	1.45	9.44	3.27	2.54	2.54	1.81	0.73
Neural stem cells, donor2	11352-117H2	63.55	9.63	21.18	3.85	3.85	1.93	1.93	1.93	0.00	1.93
Neurons, donor1	11494-119E9	38.69	4.55	6.83	2.28	2.28	2.28	2.28	3.41	4.55	3.41
Neurons, donor2	11574-120E8	44.25	3.74	12.11	3.74	5.94	0.88	0.44	3.08	4.40	0.22
Neurons, donor3	11655-122E8	101.95	4.11	13.15	4.11	6.58	0.82	0.00	7.40	1.64	2.47
Neutrophils, donor1	11233-116C9	28.77	4.64	1.86	1.86	0.93	1.86	1.86	0.93	0.93	0.00
Neutrophils, donor2	11314-117C9	34.79	2.90	8.70	5.80	0.00	0.00	0.00	0.00	2.90	0.00
Neutrophils, donor3	11390-118C4	68.41	3.05	3.67	1.22	2.44	1.22	1.22	0.61	0.00	0.61
Nucleus Pulposus Cell, donor1	11252-116F1	32.65	15.67	8.67	4.27	2.73	8.07	1.31	1.66	1.78	0.95
Nucleus Pulposus Cell, donor2	11409-118E5	55.03	17.91	8.47	6.19	2.93	9.44	1.63	6.84	5.86	1.95
Nucleus Pulposus Cell, donor3	11462-119B4	39.31	7.22	5.62	6.22	2.81	2.81	0.00	2.61	2.01	0.20
Olfactory epithelial cells, donor1	11933-125I7	64.42	13.90	1.24	1.51	2.06	1.79	1.79	0.00	0.00	0.28
Olfactory epithelial cells, donor2	11934-125I8	65.57	11.87	2.17	2.03	1.01	1.45	1.88	0.43	0.14	0.00
Olfactory epithelial cells, donor3	11935-125I9	64.24	15.89	2.16	1.82	2.04	2.16	2.16	0.23	0.11	0.00
Olfactory epithelial cells, donor4	11936-126A1	64.28	13.64	2.63	1.27	2.43	4.38	1.56	0.39	0.49	0.00
Oligodendrocyte - precursors, donor1	11496-119F2	40.92	8.43	4.81	5.42	1.81	2.41	0.60	0.00	0.60	0.60
Osteoblast - differentiated, donor1	11276-116H7	25.52	8.93	6.81	2.77	2.77	2.98	1.28	0.85	1.49	1.06
Osteoblast - differentiated, donor2	11353-117H3	19.43	12.57	2.29	2.29	0.00	2.29	2.29	2.29	4.57	3.43
Osteoblast - differentiated, donor3	11425-118G3	33.52	13.03	2.48	1.24	0.62	3.72	0.62	1.86	0.62	1.86
Osteoblast, donor1	11277-116H8	23.45	8.60	6.45	3.91	2.74	2.15	0.98	6.84	3.32	3.32
Osteoblast, donor2	11354-117H4	29.50	11.24	7.02	3.51	1.40	4.21	0.70	5.62	4.92	2.11
Osteoblast, donor3	11426-118G4	41.41	16.35	6.93	8.53	2.84	7.11	1.24	19.19	8.00	6.58
Pancreatic stromal cells, donor1	11249-116E7	32.26	14.66	7.75	5.14	2.27	3.62	1.77	2.61	1.94	0.76
Pericytes, donor1	11491-119E6	22.70	5.34	5.12	2.45	2.11	2.67	1.00	3.89	0.78	0.22
Pericytes, donor2	11571-120E5	47.76	9.28	5.43	4.75	2.04	3.85	1.36	7.47	2.04	0.91
Pericytes, donor3	11652-122E5	33.77	12.21	2.44	2.24	3.87	2.64	2.24	1.63	0.61	0.20
Perineurial Cells, donor1	11499-119F5	36.96	4.75	8.36	6.33	3.05	1.24	1.47	1.13	0.90	0.68
Perineurial Cells, donor2	11579-120F4	30.09	9.20	5.52	5.80	2.21	3.13	1.38	1.84	1.29	0.64
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	27.73	7.01	2.55	1.91	3.19	0.96	1.27	0.96	0.32	0.64
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	28.65	4.41	2.20	1.71	1.71	0.49	0.00	0.24	0.24	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	34.94	9.58	0.91	1.42	1.68	1.16	1.81	0.26	0.26	0.39
Placental Epithelial Cells, donor1	11278-116H9	12.20	3.35	1.67	0.96	0.24	0.72	1.20	0.48	0.00	0.24
Placental Epithelial Cells, donor2	11355-117H5	25.50	9.98	3.33	0.00	1.11	0.00	1.11	0.00	1.11	0.00
Placental Epithelial Cells, donor3	11427-118G5	33.96	7.66	2.36	0.98	1.18	0.59	1.96	0.00	0.39	0.79
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	24.05	12.03	1.27	1.58	0.95	2.53	3.16	0.63	0.95	0.32
Preadipocyte - breast, donor1	11467-119B9	14.26	11.26	1.88	0.94	1.69	1.88	0.75	0.00	0.38	0.38
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	12.40	6.13	1.96	0.91	1.31	1.04	0.78	0.00	0.13	0.00
Preadipocyte - breast, donor2	11328-117E5	31.75	13.51	2.93	2.25	1.58	2.70	1.13	0.45	0.00	0.68
Preadipocyte - omental, donor1	11468-119C1	13.32	10.34	2.66	0.53	1.70	1.81	2.45	0.11	0.00	0.11
Preadipocyte - omental, donor2	11329-117E6	21.39	10.04	0.44	0.00	0.87	4.80	0.44	2.18	0.44	0.87
Preadipocyte - omental, donor3	11403-118D8	47.70	13.47	0.86	0.72	0.86	2.15	2.44	0.29	0.43	0.14
Preadipocyte - perirenal, donor1	11469-119C2	22.64	5.91	1.97	1.97	0.00	1.97	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	18.12	5.84	4.30	1.54	0.61	1.54	0.31	1.54	0.31	0.61
Preadipocyte - subcutaneous, donor2	11356-117H6	62.33	11.16	4.43	7.26	5.49	2.66	2.12	1.06	1.77	0.53
Preadipocyte - subcutaneous, donor3	11428-118G6	48.36	13.45	6.13	5.45	1.02	3.58	2.55	2.38	1.19	0.51
Preadipocyte - visceral, donor1	11280-116I2	57.38	17.23	10.43	4.28	4.66	5.78	3.17	3.07	1.86	1.30
Preadipocyte - visceral, donor2	11357-117H7	66.73	15.19	8.28	6.44	1.84	3.22	1.84	4.60	0.92	0.46
Preadipocyte - visceral, donor3	11429-118G7	57.57	10.55	8.05	6.37	2.40	5.43	2.09	2.61	1.88	0.42
Prostate Epithelial Cells (polarized), donor1	11253-116F2	26.25	2.11	3.32	1.21	0.60	0.15	0.91	0.60	0.00	0.45
Prostate Epithelial Cells, donor2	11331-117E8	33.58	6.36	4.20	4.47	0.95	0.68	2.30	0.95	0.68	0.54
Prostate Epithelial Cells, donor3	11404-118D9	33.31	4.53	1.22	2.63	0.49	0.18	0.61	0.00	0.12	0.00
Prostate Stromal Cells, donor1	11254-116F3	14.69	9.23	4.78	2.39	2.28	1.03	1.03	1.03	0.46	0.91
Prostate Stromal Cells, donor2	11332-117E9	43.93	9.50	5.74	6.28	3.23	4.84	2.87	4.66	1.79	1.97
Prostate Stromal Cells, donor3	11405-118E1	29.41	10.01	4.48	2.92	1.36	2.40	0.94	1.15	0.73	0.94
Renal Cortical Epithelial Cells, donor1	11516-119H4	28.83	12.04	2.92	6.20	1.46	0.00	1.46	1.09	1.09	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	18.58	7.69	4.44	3.67	2.91	0.42	1.87	0.90	0.55	0.35
Renal Epithelial Cells, donor1	11517-119H5	29.42	8.12	4.06	1.52	0.51	1.01	1.01	1.52	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	51.93	10.67	4.27	2.85	0.71	1.42	4.27	1.42	1.42	0.00
Renal Epithelial Cells, donor3	11678-122H4	23.93	10.06	5.93	4.23	3.07	0.95	2.86	1.16	0.53	0.85
Renal Glomerular Endothelial Cells, donor1	11514-119H2	30.64	6.81	2.04	8.17	2.04	2.04	2.04	2.72	0.68	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	44.61	6.20	3.10	5.93	1.62	1.21	0.67	0.94	0.40	0.13
Renal Glomerular Endothelial Cells, donor3	11675-122H1	53.73	12.65	3.55	5.33	1.55	3.55	3.77	3.77	1.11	0.89
Renal Glomerular Endothelial Cells, donor4	11783-124B1	25.95	4.66	2.00	2.00	0.67	0.67	2.66	0.67	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	33.23	19.15	5.72	1.54	1.54	2.86	2.86	1.76	1.54	1.10
Renal Mesangial Cells, donor2	11598-120H5	48.90	12.54	6.27	5.02	1.88	1.88	1.88	3.76	0.63	3.76
Renal Mesangial Cells, donor3	11679-122H5	30.24	9.43	1.66	3.05	1.94	1.11	2.50	1.39	3.33	0.28
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	30.60	9.13	4.56	2.95	1.34	0.27	2.68	0.54	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	18.13	8.43	0.84	2.53	1.27	0.42	1.27	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	59.01	14.27	4.82	2.89	2.51	1.93	3.66	2.70	1.16	0.39
Retinal Pigment Epithelial Cells, donor0	11215-116A9	28.00	10.89	7.78	1.81	3.11	1.56	1.30	1.81	1.30	1.81
Retinal Pigment Epithelial Cells, donor1	11528-119I7	32.12	13.08	3.70	3.41	2.27	3.41	2.27	0.57	1.71	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	37.05	8.23	2.06	3.09	0.00	3.09	2.06	1.03	1.03	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	15.81	6.52	4.77	1.25	2.01	2.51	2.01	1.25	0.50	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	39.42	10.56	2.67	2.00	2.00	2.67	0.94	0.80	0.27	0.67
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	41.99	8.04	8.93	5.36	0.00	0.89	0.00	1.79	1.79	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	20.91	10.46	17.61	4.95	5.50	0.55	1.10	0.00	0.55	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	49.88	7.54	6.38	4.06	4.06	0.58	2.32	0.00	0.58	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	43.30	6.76	7.93	2.73	3.25	2.60	0.78	1.82	0.39	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	52.93	9.43	6.45	1.79	3.18	2.18	1.69	1.19	1.19	0.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	32.35	6.69	8.48	2.12	3.46	2.12	2.57	1.56	1.12	0.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	28.90	5.46	6.82	2.36	4.34	1.86	1.49	0.74	0.62	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	53.49	10.61	6.29	3.38	3.61	1.40	1.86	1.52	1.40	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	44.38	11.09	6.01	2.31	6.70	0.46	2.08	2.77	1.16	0.92
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	53.67	7.94	9.45	4.52	2.19	1.23	2.33	1.10	0.55	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	44.47	6.66	3.78	3.63	3.03	1.51	2.57	0.91	0.76	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	27.06	8.60	7.53	2.69	3.58	1.43	1.43	1.43	1.97	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	54.51	6.89	6.74	2.58	1.86	1.43	1.15	0.86	0.72	0.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	54.09	8.16	4.83	2.25	2.15	2.15	2.15	1.61	0.43	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	47.57	8.41	5.75	4.20	2.66	1.55	1.33	1.33	1.99	0.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	56.40	8.41	8.79	4.97	1.53	2.49	1.15	0.76	0.57	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	55.06	8.85	5.78	1.96	2.33	1.58	2.42	2.33	0.47	1.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	41.34	7.89	7.52	1.88	2.82	1.88	2.82	1.50	0.75	0.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	61.84	7.70	7.56	3.85	2.79	1.19	1.86	0.93	0.80	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	61.13	11.39	3.60	3.41	3.21	2.73	2.34	1.17	0.58	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	51.56	6.11	6.30	3.06	2.67	3.44	2.48	1.91	1.34	0.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	58.20	5.77	5.66	4.27	2.67	2.03	0.96	1.07	0.96	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	43.73	7.01	7.29	3.08	2.24	1.12	2.24	1.68	0.84	1.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	52.47	10.77	6.32	3.59	2.22	1.54	1.54	1.03	0.51	1.03
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	58.89	8.57	5.47	2.01	2.01	2.37	1.28	1.28	1.09	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	52.61	9.81	6.87	3.56	4.78	2.70	3.31	0.98	0.61	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	49.30	9.81	5.24	3.22	4.03	2.42	3.09	1.61	0.40	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	42.69	4.01	10.61	4.95	3.07	2.59	1.65	0.94	0.24	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	58.73	9.52	5.95	2.78	2.58	2.38	1.98	1.19	0.79	0.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	51.91	9.12	5.38	2.81	4.68	1.64	2.81	1.87	0.70	1.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	50.39	9.95	9.75	3.32	2.07	1.04	0.83	0.62	0.41	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	46.90	7.52	3.98	1.77	5.97	1.33	1.55	0.66	2.21	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	57.23	11.70	4.80	2.30	2.92	3.13	2.72	1.88	1.46	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	60.70	9.56	7.54	2.56	1.21	2.29	2.15	0.81	0.81	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	68.29	11.92	6.30	3.07	3.58	2.38	2.90	1.19	2.04	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	64.97	11.76	5.21	2.31	2.70	3.08	3.66	1.16	1.35	1.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	61.55	10.14	8.08	3.78	1.55	1.89	1.38	0.86	0.34	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	69.82	14.40	3.98	1.78	3.57	2.47	3.84	1.65	0.96	1.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	57.95	12.15	3.94	2.96	3.12	2.46	1.64	1.31	0.99	1.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	56.75	9.37	8.18	4.77	1.87	2.56	1.87	2.05	1.19	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	72.50	11.24	5.92	3.99	3.40	1.18	2.22	1.18	0.74	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	79.97	11.46	4.53	2.40	2.67	0.80	3.20	1.60	1.33	0.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	55.44	6.08	7.60	8.02	2.63	1.66	0.97	2.07	0.97	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	53.81	11.43	7.86	4.29	2.62	2.86	2.14	3.57	1.90	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	115.48	15.72	8.46	4.84	3.02	2.02	2.82	2.02	1.01	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	49.63	6.69	8.66	3.20	3.30	0.94	0.94	0.94	1.04	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	52.75	9.78	9.08	4.54	3.49	2.45	2.45	1.05	0.00	1.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	71.02	10.58	5.14	4.84	0.91	2.72	2.12	1.21	1.81	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	49.57	6.61	8.93	2.20	3.18	1.71	0.98	0.86	0.24	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	51.38	9.90	12.23	4.80	5.97	2.33	2.91	1.46	1.02	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	40.76	9.13	6.08	4.87	1.22	1.83	0.61	1.22	1.83	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	45.81	3.62	12.06	2.41	2.71	0.60	0.00	0.90	0.30	1.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	39.58	7.92	11.08	4.52	2.26	2.71	1.58	0.68	0.68	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	64.10	11.38	7.49	3.59	5.09	3.59	0.90	0.60	1.80	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	29.75	3.42	11.93	3.19	1.30	0.59	0.24	1.18	0.24	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	42.26	7.47	10.67	4.70	1.49	1.71	1.92	0.64	1.07	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	55.29	6.01	10.82	4.21	1.80	0.00	1.20	3.00	2.40	1.20
Schwann Cells, donor1	11498-119F4	53.79	7.52	3.76	6.02	1.69	2.07	0.56	2.44	0.94	0.19
Schwann Cells, donor2	11578-120F3	30.62	0.00	3.40	6.80	0.00	3.40	0.00	6.80	0.00	3.40
Schwann Cells, donor3	11659-122F3	46.66	6.79	5.04	3.94	1.31	2.41	2.63	4.60	1.97	0.88
Sebocyte, donor1	11220-116B5	53.13	19.17	2.19	4.38	2.74	1.10	8.22	0.00	0.00	0.00
Sebocyte, donor2	11301-117B5	53.31	7.35	3.22	2.76	0.92	1.84	2.30	0.00	0.46	0.00
Sebocyte, donor3	11378-118B1	44.31	8.66	2.27	1.44	1.03	2.27	1.86	0.21	0.00	0.00
Sertoli Cells, donor1	11255-116F4	18.22	9.94	4.97	1.66	3.31	3.31	0.00	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	28.24	8.47	2.82	0.00	2.82	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	40.91	11.26	8.97	3.78	3.08	5.45	1.94	3.52	1.85	2.29
Skeletal Muscle Cells, donor2	11358-117H8	13.01	2.89	2.17	2.89	0.72	2.17	0.00	1.45	0.00	0.72
Skeletal Muscle Cells, donor3	11430-118G8	47.65	19.23	9.20	8.36	1.67	1.67	1.67	24.25	5.02	7.52
Skeletal Muscle Cells, donor4	11451-119A2	40.22	10.05	7.38	5.81	3.46	4.24	0.94	4.24	2.67	0.94
Skeletal Muscle Cells, donor5	11455-119A6	37.61	7.88	7.88	5.20	3.12	2.68	0.74	2.53	1.93	1.04
Skeletal Muscle Cells, donor6	11459-119B1	42.94	8.77	6.93	5.54	3.08	1.85	1.08	2.31	1.23	0.31
Skeletal Muscle Satellite Cells, donor1	11240-116D7	25.71	11.09	12.73	7.56	4.03	3.15	1.76	1.26	1.51	0.50
Skeletal Muscle Satellite Cells, donor2	11321-117D7	32.53	13.13	7.42	4.71	1.85	2.57	1.14	2.28	1.14	0.43
Skeletal Muscle Satellite Cells, donor3	11397-118D2	50.40	13.59	6.35	5.75	2.18	3.97	1.59	2.28	1.98	1.09
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	35.30	9.52	6.40	3.45	2.36	4.21	1.26	2.61	2.36	3.20
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	43.43	7.24	3.62	3.62	1.45	1.45	0.72	5.79	2.90	2.90
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	31.10	4.40	8.94	7.16	3.85	3.72	0.55	19.81	7.43	6.60
Skin - palm, donor1	10286-104F7	110.13	5.37	2.69	2.69	0.00	0.00	2.69	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	22.49	6.78	2.88	5.62	0.86	0.86	1.87	0.58	0.14	0.43
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	39.26	20.45	4.91	10.63	0.00	2.45	1.64	0.82	0.82	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	25.19	7.66	3.51	3.38	0.65	0.52	2.73	0.39	0.26	0.26
Small Airway Epithelial Cells, donor1	11256-116F5	15.85	6.67	2.36	3.06	1.67	0.56	3.48	0.42	0.42	0.56
Small Airway Epithelial Cells, donor2	11334-117F2	41.35	9.71	2.53	4.36	0.28	0.70	3.09	0.14	0.00	0.28
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	36.37	15.22	11.00	10.15	0.63	2.75	6.55	1.48	0.21	0.21
Small Airway Epithelial Cells, donor3	11406-118E2	51.27	11.39	1.72	2.25	1.05	1.05	2.77	0.45	0.30	0.22
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	43.51	6.79	5.86	7.10	1.23	2.16	0.00	0.62	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	18.23	2.89	3.11	3.33	1.56	1.33	0.89	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	24.69	11.17	3.53	1.76	1.18	3.53	1.76	1.76	0.59	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	21.88	10.39	3.76	2.21	1.55	1.99	1.10	1.10	0.88	0.44
Smooth Muscle Cells - Aortic, donor2	11360-117I1	23.63	5.51	3.94	1.18	0.79	1.18	0.39	1.58	0.79	0.79
Smooth Muscle Cells - Aortic, donor3	11432-118H1	27.04	9.27	3.86	1.55	3.09	2.32	0.77	2.32	1.55	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	31.02	19.01	3.00	1.00	1.00	3.00	1.00	2.00	3.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	15.57	7.72	3.46	2.00	2.13	1.33	1.06	1.33	1.20	0.40
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	48.10	13.74	5.32	3.55	2.44	6.21	2.22	2.44	1.77	0.44
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	16.90	4.10	4.10	5.51	1.28	1.79	0.38	1.41	0.77	0.13
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	21.16	6.51	3.91	3.58	2.93	3.26	0.33	0.98	1.30	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	27.76	11.52	5.32	3.25	1.48	3.84	1.18	1.48	1.48	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	29.33	11.67	3.70	4.41	1.14	1.42	2.42	0.71	0.43	1.28
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	25.87	9.11	3.74	3.58	1.46	2.28	0.81	2.28	0.81	0.65
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	34.71	8.83	5.78	4.26	0.00	4.57	1.52	1.22	0.91	0.61
Smooth Muscle Cells - Carotid, donor1	11285-116I7	22.73	8.08	7.58	3.54	2.27	1.77	0.76	2.27	2.53	1.01
Smooth Muscle Cells - Carotid, donor2	11362-117I3	24.48	0.00	0.00	0.00	6.12	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	16.21	1.91	2.86	0.95	1.91	0.95	0.95	0.48	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	14.16	7.23	5.75	1.77	1.33	2.80	1.18	1.03	0.29	0.15
Smooth Muscle Cells - Colonic, donor2	11320-117D6	24.11	12.48	3.23	1.51	1.08	1.72	1.72	0.86	0.22	0.65
Smooth Muscle Cells - Colonic, donor3	11396-118D1	28.76	10.92	4.30	3.36	1.57	2.52	1.68	0.94	1.15	0.42
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	24.44	6.81	4.02	2.17	2.63	1.55	1.08	1.39	0.93	0.31
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	16.17	6.47	4.31	3.23	5.39	4.31	1.08	2.16	0.00	4.31
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	24.51	5.08	3.59	5.68	0.60	1.20	0.60	0.60	0.00	0.30
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	26.63	10.24	5.12	2.73	1.02	1.02	1.71	1.02	0.00	0.68
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	20.02	9.42	6.99	3.22	1.73	1.88	1.33	0.86	0.86	0.31
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	56.76	25.06	10.97	3.82	7.35	17.81	3.82	3.12	1.71	1.31
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	26.62	10.47	4.78	5.46	1.37	2.05	1.14	0.91	0.46	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	15.70	2.42	0.60	3.62	0.60	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	57.49	7.95	6.09	4.24	3.18	3.18	1.06	1.32	1.32	0.53
Smooth Muscle Cells - Prostate, donor1	11257-116F6	30.89	7.72	8.26	2.66	1.60	2.40	0.40	2.00	1.20	0.40
Smooth Muscle Cells - Prostate, donor2	11335-117F3	34.69	9.02	5.38	2.50	1.88	2.63	0.63	0.63	0.88	0.25
Smooth Muscle Cells - Prostate, donor3	11465-119B7	27.40	7.10	4.82	1.52	1.01	2.03	1.01	1.27	1.52	1.27
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	22.92	8.90	5.28	2.86	1.51	1.51	0.90	2.41	1.36	1.06
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	27.76	9.00	2.25	5.25	0.75	0.00	0.00	8.25	0.75	0.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	135.68	15.51	2.58	1.29	2.58	1.29	0.00	1.29	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	23.72	6.51	4.19	1.40	0.93	1.40	1.40	0.93	2.33	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	24.74	5.55	2.02	2.52	2.02	2.02	2.02	0.00	0.50	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	20.06	2.51	1.88	1.57	1.57	1.25	1.57	0.31	0.63	0.63
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	15.93	6.49	1.47	0.59	0.59	3.24	0.59	2.06	1.18	0.29
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	68.06	12.58	11.16	7.66	2.83	6.41	2.83	3.92	2.67	1.08
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	39.71	8.41	6.54	3.27	0.93	2.34	1.40	1.40	0.93	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	15.26	7.92	2.45	2.45	2.45	1.01	1.44	1.15	0.72	0.58
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	23.71	5.35	2.80	2.55	3.06	0.76	0.25	1.53	0.76	0.76
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	30.27	4.51	4.89	6.77	0.75	1.32	0.38	2.82	1.32	0.75
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	35.08	8.24	4.47	2.52	2.66	1.12	1.54	0.98	0.70	0.28
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	23.13	6.95	2.09	3.85	1.59	1.59	0.92	0.25	0.67	0.25
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	10.48	2.86	0.00	1.43	0.00	0.48	0.48	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	19.57	9.54	2.20	0.98	1.47	0.73	1.71	1.22	0.00	0.73
Smooth Muscle Cells - Uterine, donor1	11258-116F7	29.17	4.20	5.52	1.55	1.33	1.33	0.88	0.66	1.10	0.22
Smooth Muscle Cells - Uterine, donor3	11466-119B8	16.09	2.93	4.10	3.22	2.34	0.00	0.00	1.76	0.00	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	38.87	14.38	5.83	3.11	2.14	5.05	1.55	0.39	0.97	0.19
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	32.53	8.46	2.38	3.44	1.32	2.38	1.32	1.06	0.53	0.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	13.76	10.41	5.95	2.23	3.35	2.98	1.86	0.00	0.37	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	28.39	11.14	3.59	3.95	1.44	3.59	0.72	0.36	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	23.00	9.65	1.70	2.84	1.42	1.70	1.70	1.99	1.42	0.57
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	44.11	15.75	8.27	5.91	1.97	6.30	1.97	1.58	0.39	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	37.84	13.46	4.57	3.81	1.78	6.09	1.02	1.27	0.00	0.76
Smooth muscle cells - airway, control, donor2	11967-126D5	55.90	18.77	6.79	6.79	0.80	2.40	2.40	0.80	0.80	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	50.58	15.05	4.18	5.02	0.42	2.93	1.67	1.25	0.84	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	41.25	16.04	5.50	4.13	3.21	7.79	1.38	1.38	1.38	0.00
Synoviocyte, donor1	11291-117A4	19.36	10.44	4.21	1.85	1.51	2.36	0.67	0.67	0.50	0.17
Synoviocyte, donor2	11368-117I9	28.66	14.42	1.68	2.51	1.68	1.17	0.67	0.17	0.00	0.17
Synoviocyte, donor3	11440-118H9	35.52	12.73	2.46	2.46	0.22	2.01	0.67	0.22	0.22	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	67.89	15.37	7.86	1.79	2.50	3.22	1.07	1.79	0.71	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	41.62	11.89	1.98	1.98	1.98	1.98	0.00	0.00	1.98	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	43.07	9.96	2.78	3.70	1.85	2.08	1.16	0.00	0.93	0.23
Tracheal Epithelial Cells, donor1	11292-117A5	17.49	5.38	3.30	2.80	2.15	0.43	1.29	0.36	0.14	0.07
Tracheal Epithelial Cells, donor2	11369-118A1	17.40	6.57	1.16	1.55	0.39	0.00	0.77	0.77	0.77	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	15.46	1.72	2.86	1.15	1.72	0.57	0.57	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	37.89	11.20	4.55	2.34	2.71	1.85	1.11	0.37	0.12	0.12
Urethra, donor2	10319-105A4	77.33	12.59	8.99	1.80	1.80	3.60	0.00	1.80	0.00	0.00
Urothelial Cells, donor1	11520-119H8	20.99	5.84	2.39	3.19	0.80	0.53	3.72	2.39	0.80	0.27
Urothelial Cells, donor2	11600-120H7	22.83	8.01	2.00	3.61	1.20	0.00	1.20	0.40	0.00	0.00
Urothelial Cells, donor3	11681-122H7	21.09	8.94	0.69	4.81	2.06	0.00	1.38	0.00	0.00	0.00
Urothelial cells, donor0	11216-116B1	26.75	8.69	5.13	5.13	2.01	0.45	2.90	0.00	0.22	0.22
Whole blood (ribopure), donor090309, donation1	12179-129A1	32.03	9.79	1.78	1.78	7.12	0.00	1.78	3.56	1.78	1.78
Whole blood (ribopure), donor090309, donation2	12180-129A2	40.03	8.58	2.86	2.86	4.29	0.00	1.43	4.29	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	47.23	6.16	0.68	4.79	2.05	0.00	0.68	2.05	0.68	0.68
Whole blood (ribopure), donor090325, donation1	12176-128I7	38.57	5.51	1.03	1.03	3.10	0.69	1.38	0.69	0.69	0.69
Whole blood (ribopure), donor090325, donation2	12177-128I8	19.75	8.13	2.32	1.16	3.49	0.00	2.91	1.74	0.58	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	32.28	4.16	3.12	0.00	4.16	2.08	1.04	2.08	0.00	1.04
Whole blood (ribopure), donor090612, donation2	12183-129A5	43.14	7.34	0.92	2.75	2.75	0.92	0.00	1.84	2.75	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	42.91	9.13	2.74	1.83	0.91	0.91	0.00	0.00	0.91	3.65
Wilms' tumor cell line:G-401	10809-111A8	36.14	7.15	3.95	1.23	1.23	0.25	2.34	0.62	0.12	0.00
Wilms' tumor cell line:HFWT	10597-108E3	59.84	0.88	5.28	2.64	4.40	0.00	0.00	1.76	1.76	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	96.64	13.97	7.54	6.42	1.68	1.12	1.96	1.12	0.84	0.56
achilles tendon, donor2	10292-104G4	59.93	4.13	4.13	8.27	0.00	2.07	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	48.19	11.22	6.37	3.57	10.71	0.51	2.80	1.27	3.06	0.51
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	66.87	7.89	4.18	2.32	6.73	1.63	1.16	0.46	0.46	0.23
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	62.80	9.73	8.67	6.29	9.62	0.71	4.63	3.32	3.09	0.59
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	65.04	5.44	6.26	2.99	8.44	0.27	1.09	2.18	0.82	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	7.40	5.08	3.17	4.44	2.54	0.21	1.48	0.42	0.42	0.42
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	30.84	10.58	10.58	11.46	3.53	1.32	1.76	1.76	2.64	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	38.79	12.66	7.76	9.39	6.53	1.23	2.45	2.45	2.45	2.45
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	45.82	5.82	8.15	5.82	5.44	0.39	2.33	5.05	1.55	3.49
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	25.76	6.62	3.13	1.10	2.58	0.18	1.66	0.18	0.00	0.18
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	23.40	7.80	3.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	13.71	3.25	6.74	8.13	1.63	0.00	0.93	0.46	0.46	0.23
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	26.93	8.80	3.37	2.07	3.88	0.78	1.29	1.04	0.52	0.26
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	29.81	13.74	5.55	2.63	1.75	0.29	2.63	0.58	0.29	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	28.82	16.27	1.39	4.65	1.86	0.93	3.25	0.46	0.93	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	42.05	13.20	9.21	4.91	1.23	0.61	6.14	0.31	0.00	0.92
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	29.87	16.21	8.11	2.13	2.99	0.43	3.41	0.43	0.00	0.43
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	24.87	9.10	5.76	2.73	1.21	0.61	5.16	0.30	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	27.68	12.28	7.46	3.85	1.93	0.72	4.57	0.72	0.72	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	17.60	5.79	2.23	2.00	0.45	0.89	0.89	0.00	0.22	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	67.04	31.35	7.34	7.67	7.67	5.67	5.34	7.34	1.33	5.34
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	117.07	53.89	9.29	5.57	3.72	1.86	1.86	1.86	1.86	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	19.21	13.56	1.88	3.39	1.51	1.13	0.75	1.51	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	59.31	44.92	17.01	23.12	5.23	12.21	4.36	30.09	16.14	26.17
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	142.46	71.23	9.37	1.87	0.00	9.37	7.50	7.50	3.75	3.75
adenocarcinoma cell line:IM95m	10796-110I4	101.97	9.66	4.71	3.30	3.06	0.94	0.47	0.94	0.00	1.18
adipose tissue, adult, pool1	10010-101C1	30.40	9.62	3.88	2.33	1.40	3.26	0.78	0.16	0.16	0.31
adipose, donor1	10184-103D4	36.94	3.52	45.15	39.29	10.56	0.00	3.52	13.49	10.56	11.73
adipose, donor2	10185-103D5	66.10	1.62	21.90	3.65	6.49	0.00	0.41	4.87	6.89	1.22
adipose, donor3	10186-103D6	73.25	4.36	17.70	7.62	6.81	0.54	2.45	10.07	8.17	3.54
adipose, donor4	10187-103D7	72.81	12.13	14.73	4.33	4.33	2.60	1.73	5.20	3.47	5.20
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	134.78	11.36	3.16	0.47	1.89	0.79	2.68	1.42	1.26	0.16
adrenal gland, adult, pool1	10081-102A9	61.84	7.28	0.00	3.64	0.00	0.00	0.00	3.64	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	7.07	0.53	0.67	1.07	1.20	0.00	0.13	0.00	0.13	0.13
alveolar cell carcinoma cell line:SW 1573	10708-109H6	52.52	4.64	3.57	0.71	5.00	0.36	2.14	0.36	0.00	0.00
amniotic membrane cells, donor1	12235-129G3	38.49	9.04	0.46	1.62	0.46	0.46	1.39	0.23	0.00	0.00
amniotic membrane cells, donor2	12236-129G4	35.84	21.30	2.70	1.69	0.34	2.70	2.70	1.35	1.35	0.34
amniotic membrane cells, donor3	12237-129G5	22.68	6.78	0.59	0.59	0.00	0.29	0.88	0.00	0.00	0.00
amygdala - adult, donor10196	10167-103B5	154.15	2.37	5.93	3.56	4.74	0.00	1.19	1.19	1.19	0.00
amygdala, adult, donor10252	10151-102I7	103.41	4.66	5.68	3.04	4.66	0.61	1.22	1.62	1.01	1.22
amygdala, newborn, donor10223	10360-105E9	71.65	3.23	8.07	1.94	1.61	0.97	0.97	2.58	0.32	0.65
anaplastic carcinoma cell line:8305C	10428-106D5	46.98	13.62	9.04	6.75	2.16	1.66	1.91	1.91	1.40	1.15
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	84.06	11.69	3.97	3.53	3.09	0.44	3.31	0.44	0.00	0.22
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	61.13	6.01	10.02	3.01	2.00	0.00	2.34	4.01	6.35	0.33
aorta, adult, pool1	10052-101G7	74.14	10.00	2.94	0.98	1.37	1.96	0.20	0.39	0.39	0.00
appendix, adult	10189-103D9	49.29	9.70	8.54	1.16	2.72	2.72	1.94	0.39	0.78	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	28.20	7.57	1.38	0.00	1.38	0.34	2.41	0.00	0.00	0.00
artery, adult	10190-103E1	100.54	10.87	6.79	2.72	1.36	0.00	0.00	1.36	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	17.96	12.02	8.26	2.90	2.46	0.43	2.90	2.46	0.58	1.59
b cell line:RPMI1788	10427-106D4	23.64	5.65	0.30	0.15	2.97	0.30	1.19	0.00	0.00	0.15
basal cell carcinoma cell line:TE 354.T	10702-109G9	17.48	6.94	1.39	1.11	3.05	1.11	0.83	0.00	0.00	0.28
bile duct carcinoma cell line:HuCCT1	10432-106D9	53.78	21.43	3.18	7.14	2.08	6.75	4.27	1.98	1.09	1.49
bile duct carcinoma cell line:TFK-1	10496-107C1	17.24	2.85	2.01	0.50	2.18	0.00	0.67	0.00	0.00	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	13.98	5.59	6.15	1.68	3.91	0.00	2.80	0.00	0.00	0.00
bladder, adult, pool1	10011-101C2	27.38	5.32	4.35	1.74	0.87	1.41	0.65	0.00	0.11	0.11
blood, adult, pool1	10053-101G8	70.87	13.29	2.21	8.86	2.21	0.00	0.00	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	110.47	26.55	10.28	0.86	2.57	2.57	6.85	2.57	0.86	0.86
bone marrow, adult	10192-103E3	24.97	3.37	4.05	1.35	0.00	1.35	2.02	0.67	0.00	0.00
brain, adult, donor1	10084-102B3	79.96	3.08	8.20	6.15	3.08	0.00	1.03	6.15	1.03	0.00
brain, adult, pool1	10012-101C3	53.12	3.79	13.92	4.90	4.23	0.56	1.22	1.56	1.22	1.34
brain, fetal, pool1	10085-102B4	197.68	13.36	37.40	10.69	10.69	2.67	0.00	21.37	13.36	2.67
breast carcinoma cell line:MCF7	10482-107A5	39.31	10.57	1.65	1.98	0.33	0.66	0.33	0.33	0.00	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	3.12	0.50	0.25	0.00	0.00	0.00	0.25	0.12	0.00	0.00
breast, adult, donor1	10080-102A8	88.39	8.84	0.63	2.53	0.00	1.89	1.26	0.00	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	57.55	10.29	3.43	1.14	1.14	0.51	2.41	0.76	0.13	0.00
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	92.15	24.12	20.10	8.35	6.80	2.47	4.95	4.33	2.47	5.88
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	24.40	9.21	14.04	1.38	13.58	0.92	3.45	1.15	0.46	0.92
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	56.89	8.23	1.21	2.91	3.87	0.97	1.94	0.73	0.24	0.24
carcinoid cell line:NCI-H1770	10703-109H1	86.04	7.05	11.28	4.70	5.17	1.41	1.88	1.41	0.00	1.41
carcinoid cell line:NCI-H727	10735-110B6	100.41	27.35	6.02	2.30	2.19	3.28	5.47	1.42	0.11	0.55
carcinoid cell line:SK-PN-DW	10719-109I8	27.89	0.00	13.63	6.65	3.17	0.00	0.00	0.95	0.95	2.85
carcinosarcoma cell line:JHUCS-1	10642-109A3	84.91	8.25	9.32	2.93	5.32	2.40	1.06	2.93	2.40	0.80
caudate nucleus - adult, donor10196	10177-103C6	111.68	1.15	11.51	3.45	1.15	0.00	0.00	0.00	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	72.28	1.51	7.20	2.18	4.52	1.00	0.50	1.67	0.50	0.50
caudate nucleus, adult, donor10258	10379-105H1	82.53	2.29	8.41	5.35	3.82	0.00	0.76	0.76	1.53	0.76
caudate nucleus, newborn, donor10223	10354-105E3	72.88	3.30	10.99	2.93	5.13	0.00	1.10	1.10	1.83	1.10
cerebellum - adult, donor10196	10173-103C2	235.97	5.83	17.48	0.00	0.00	0.00	0.00	0.00	0.00	2.91
cerebellum, adult, donor10252	10166-103B4	155.65	3.84	8.54	1.92	3.20	0.64	0.64	1.49	0.43	1.28
cerebellum, adult, pool1	10083-102B2	145.91	1.72	12.07	3.10	4.48	1.72	0.34	1.72	1.72	1.03
cerebellum, newborn, donor10223	10357-105E6	105.45	4.15	14.95	2.49	4.15	2.49	0.83	3.32	0.00	5.81
cerebral meninges, adult	10188-103D8	53.45	7.06	6.81	6.05	6.56	0.76	2.02	2.02	1.01	2.52
cerebrospinal fluid, donor2	10294-104G6	86.98	5.12	5.12	2.92	1.46	1.46	0.73	0.73	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	13.66	2.88	2.30	5.18	3.02	0.43	0.29	0.29	0.14	0.29
cervical cancer cell line:ME-180	10553-107I4	28.17	2.49	2.65	1.66	0.99	0.17	0.17	0.66	0.00	0.33
cervix, adult, pool1	10013-101C4	36.85	10.18	4.62	2.20	1.68	2.62	0.84	0.21	0.21	0.21
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	42.50	7.38	2.23	0.56	2.37	1.25	0.84	0.28	0.42	0.14
chondrosarcoma cell line:SW 1353	10700-109G7	92.74	13.06	1.31	2.61	0.00	1.31	0.00	1.31	2.61	0.00
choriocarcinoma cell line:BeWo	10423-106C9	19.01	3.48	10.44	5.47	6.21	0.00	0.87	0.50	0.50	0.50
choriocarcinoma cell line:SCH	10785-110H2	28.83	0.25	1.72	0.86	0.86	0.00	0.00	0.12	0.25	0.00
choriocarcinoma cell line:T3M-3	10618-108G6	48.62	0.24	1.42	1.42	2.61	0.00	0.00	0.00	0.00	0.24
chorionic membrane cells, donor1	12238-129G6	15.67	4.56	0.85	1.42	0.28	0.28	0.28	0.00	0.28	0.00
chorionic membrane cells, donor2	12239-129G7	43.85	11.73	6.36	7.26	2.68	2.29	2.68	2.19	0.89	0.70
chorionic membrane cells, donor3	12240-129G8	17.03	1.65	1.65	0.55	0.55	0.00	0.55	0.00	0.00	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	7.07	0.00	2.02	4.04	2.02	1.01	0.00	2.02	2.02	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	31.50	16.33	10.57	8.26	6.15	4.03	2.31	1.73	1.73	1.34
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	34.42	12.67	5.91	5.70	0.84	1.06	0.63	0.63	1.27	0.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	42.37	0.77	9.76	6.16	3.85	0.00	0.51	0.77	1.03	0.51
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	54.18	1.69	11.85	6.29	4.60	0.48	0.24	0.48	2.66	0.24
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	49.88	2.85	9.57	4.28	3.66	0.20	0.20	1.43	1.02	0.20
chronic myelogenous leukemia cell line:K562	10454-106G4	41.22	1.77	17.08	6.18	8.24	0.29	0.59	3.53	3.83	1.47
chronic myelogenous leukemia cell line:KU812	10409-106B4	34.14	25.80	5.47	2.61	4.43	4.43	6.78	1.30	0.26	0.26
clear cell carcinoma cell line:JHOC-5	10638-108I8	17.60	2.51	3.20	0.69	2.51	0.00	1.37	0.23	0.00	0.00
clear cell carcinoma cell line:TEN	10636-108I6	18.39	9.20	5.55	3.12	1.91	1.56	1.21	1.21	0.00	0.17
colon carcinoma cell line:CACO-2	10513-107D9	4.58	0.55	0.37	0.18	0.37	0.00	0.00	0.37	0.00	0.00
colon carcinoma cell line:COLO-320	10420-106C6	22.80	3.42	9.50	4.18	2.66	0.38	0.76	0.38	0.38	0.00
colon, adult, donor1	10082-102B1	84.49	7.14	3.57	3.57	1.19	3.57	0.00	0.00	1.19	0.00
colon, adult, pool1	10014-101C5	39.48	8.70	5.64	2.59	2.59	2.00	1.29	0.35	0.00	0.24
colon, fetal, donor1	10070-101I7	63.65	3.71	12.36	7.42	2.47	0.00	1.24	2.47	3.09	0.00
common myeloid progenitor CMP, donor1	12130-128D6	96.25	18.33	4.58	13.75	13.75	0.00	9.17	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	25.04	0.00	0.00	0.00	0.00	0.00	25.04	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	7.22	4.25	1.27	1.70	3.40	0.00	0.85	0.42	0.00	0.85
cord blood derived cell line:COBL-a 24h infection	10453-106G3	8.75	5.74	1.36	0.91	2.72	0.30	2.26	0.30	0.30	0.15
cord blood derived cell line:COBL-a untreated	10449-106F8	6.91	5.64	2.40	2.54	2.40	0.71	2.12	0.28	0.71	0.14
corpus callosum, adult, pool1	10042-101F6	44.45	5.42	12.71	2.10	2.54	0.77	0.66	1.99	1.11	1.00
cruciate ligament, donor2	10295-104G7	72.13	1.62	4.05	4.05	1.62	4.86	0.00	0.00	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	85.07	4.82	7.22	5.62	1.61	3.21	0.00	2.41	2.41	0.80
diencephalon, adult	10193-103E4	55.44	1.92	8.64	1.44	1.68	0.48	0.00	2.16	0.00	0.24
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	37.89	8.73	4.59	1.38	10.10	0.92	1.61	1.15	0.23	0.23
ductal cell carcinoma cell line:KLM-1	10438-106E6	22.05	9.74	2.56	2.56	1.54	0.51	2.05	0.26	0.00	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	34.18	10.59	7.70	9.63	4.57	10.83	0.72	17.09	5.06	8.91
ductus deferens, adult	10196-103E7	40.37	10.96	3.99	1.00	0.00	1.00	1.00	0.00	0.00	1.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	103.70	7.20	12.96	4.32	1.44	5.76	0.00	4.32	2.88	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	43.40	4.41	7.36	2.94	1.47	1.47	0.74	2.94	0.74	0.00
dura mater, adult, donor1	10041-101F5	37.49	8.01	5.86	2.15	1.73	1.98	0.91	0.08	0.33	0.17
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	8.88	3.11	5.55	4.00	6.22	0.67	1.33	1.33	1.11	2.89
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	18.05	6.45	14.76	4.87	8.74	1.00	1.58	2.01	2.15	1.43
embryonic pancreas cell line:1B2C6	10604-108F1	93.11	12.33	3.70	1.23	3.70	4.32	3.70	1.85	1.85	1.23
embryonic pancreas cell line:1C3D3	10605-108F2	29.67	6.96	3.33	1.51	2.72	0.61	2.72	1.51	1.21	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	65.45	12.97	5.87	3.09	4.01	2.78	2.78	2.16	1.23	1.54
embryonic pancreas cell line:2C6	10603-108E9	66.99	14.45	9.19	1.31	3.94	0.00	3.94	1.31	1.31	1.31
endometrial carcinoma cell line:OMC-2	10497-107C2	32.18	9.05	6.37	2.68	4.36	1.01	1.01	1.34	0.34	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	59.26	2.54	7.07	3.26	5.26	0.91	0.91	2.17	2.72	1.63
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	38.92	5.79	3.54	1.61	3.06	0.32	0.96	0.48	0.48	0.32
epidermoid carcinoma cell line:A431	10426-106D3	36.46	9.34	3.78	2.33	3.78	0.67	1.67	0.11	0.33	0.22
epidermoid carcinoma cell line:Ca Ski	10431-106D8	45.42	7.81	3.52	2.31	1.54	1.21	1.54	0.33	0.11	0.11
epididymis, adult	10197-103E8	42.49	9.84	5.02	2.30	1.67	0.84	0.42	0.42	0.42	0.21
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	54.11	4.97	8.16	3.19	4.61	1.06	1.77	0.89	1.24	0.89
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	15.34	3.15	1.18	1.18	1.18	0.39	1.57	0.00	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	26.47	6.55	2.49	0.66	1.05	0.00	1.05	0.39	0.00	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	23.23	8.07	1.18	0.89	1.38	0.79	2.17	0.39	0.00	0.10
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	28.46	8.29	1.79	0.90	1.12	0.56	1.23	0.22	0.45	0.34
esophagus, adult, pool1	10015-101C6	28.56	8.60	3.50	0.96	1.27	2.02	1.91	0.00	0.11	0.00
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	35.94	4.26	5.51	2.88	3.01	0.63	2.13	0.75	0.38	0.13
eye - muscle inferior rectus, donor1	10272-104E2	84.51	2.41	2.41	2.41	0.00	4.83	0.00	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	42.08	6.31	4.21	4.21	0.00	2.10	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	81.85	8.93	1.49	1.49	0.00	0.00	0.00	1.49	0.00	0.00
eye - muscle superior, donor2	10297-104G9	44.71	3.44	0.00	1.15	1.15	1.15	0.00	0.00	1.15	0.00
eye - vitreous humor, donor1	10268-104D7	55.38	7.29	0.00	1.46	0.00	0.00	0.00	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	84.91	5.85	5.59	4.32	2.54	0.51	0.25	2.54	1.78	2.29
fibrosarcoma cell line:HT-1080	10758-110E2	51.67	10.77	3.46	7.18	2.31	0.64	1.92	1.15	0.38	0.38
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	89.03	19.71	2.61	1.42	1.90	2.14	3.80	0.95	0.71	0.24
frontal lobe, adult, pool1	10040-101F4	60.99	7.32	10.88	4.13	4.32	0.94	2.53	2.53	1.22	1.50
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	53.14	6.31	3.30	0.90	2.70	0.30	2.10	0.30	0.90	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	28.71	10.42	7.59	3.84	6.40	1.10	1.65	0.55	0.55	0.09
gall bladder, adult	10198-103E9	49.98	20.04	7.00	4.59	1.45	6.04	0.97	0.48	0.24	0.48
gamma delta positive T cells, donor1	11937-126A2	56.37	11.81	1.61	0.54	1.61	0.54	4.29	0.00	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	51.54	10.46	2.61	0.75	5.98	0.37	1.87	0.75	0.37	0.75
gastric adenocarcinoma cell line:MKN1	10614-108G2	41.61	16.47	1.06	1.69	0.42	4.86	2.11	0.63	0.21	0.21
gastric adenocarcinoma cell line:MKN45	10612-108F9	42.36	13.73	6.00	2.51	1.16	0.58	2.32	0.39	0.19	0.00
gastric cancer cell line:AZ521	10549-107H9	53.45	10.98	6.89	1.31	8.20	0.66	5.74	0.98	1.80	0.00
gastric cancer cell line:GSS	10560-108A2	100.67	7.32	7.32	1.83	3.66	0.92	0.92	2.75	0.92	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	56.66	6.17	3.88	1.14	2.51	1.14	1.14	1.37	0.69	0.23
giant cell carcinoma cell line:LU65	10487-107B1	8.49	2.41	1.61	1.03	1.49	0.34	0.80	0.11	0.23	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	35.13	12.46	6.86	3.36	4.06	1.68	1.54	0.70	0.14	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	40.16	7.98	0.75	0.50	1.25	0.00	2.74	0.00	0.00	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	53.94	21.11	5.17	2.96	4.01	3.69	3.06	1.37	0.32	1.27
glioblastoma cell line:A172, tech_rep2	10444-106F3	85.53	19.66	3.37	2.67	5.06	5.34	3.93	0.70	0.56	0.56
glioblastoma cell line:T98G	10485-107A8	47.79	15.34	4.64	2.76	2.43	4.19	1.55	1.55	0.44	0.22
glioma cell line:GI-1	10413-106B8	32.51	8.49	4.98	2.05	2.05	2.64	1.17	1.17	0.29	0.88
globus pallidus - adult, donor10196	10175-103C4	123.19	3.64	8.02	6.56	0.73	1.46	0.73	1.46	1.46	0.73
globus pallidus, adult, donor10252	10161-103A8	76.40	5.86	6.83	2.44	2.20	2.20	1.22	1.22	0.73	0.73
globus pallidus, adult, donor10258	10367-105F7	58.88	6.85	13.69	1.37	0.00	0.00	0.00	0.00	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	39.44	4.80	6.40	2.66	1.60	1.60	1.60	2.66	3.20	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	66.07	26.92	0.00	2.45	2.45	4.89	7.34	2.45	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	10.93	21.86	0.00	0.00	10.93	0.00	10.93	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	36.59	10.45	5.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	46.08	18.24	2.88	1.60	2.56	3.84	1.60	1.60	0.64	0.96
hIPS +CCl2, biol_rep1	14383-156B9	33.52	5.51	17.45	6.89	2.30	0.46	2.30	3.67	3.21	0.46
hIPS +CCl2, biol_rep2	14384-156C1	31.55	7.32	17.38	5.94	0.91	0.46	0.91	1.37	0.91	0.00
hIPS +CCl2, biol_rep3	14385-156C2	32.20	3.86	21.90	5.15	1.29	0.00	1.29	1.93	3.86	0.64
hIPS, biol_rep1	14380-156B6	31.62	8.62	1.44	2.87	0.00	0.00	0.00	5.75	2.87	0.00
hIPS, biol_rep2	14381-156B7	48.70	5.49	13.72	6.86	0.69	1.37	2.74	1.37	2.74	0.00
hIPS, biol_rep3	14382-156B8	65.10	2.21	7.72	1.10	1.10	1.10	1.10	1.10	1.10	0.00
hairy cell leukemia cell line:Mo	10712-109I1	44.25	10.92	2.87	2.01	6.03	0.86	0.86	3.74	2.01	1.44
heart - mitral valve, adult	10205-103F7	39.76	9.57	2.99	1.20	1.79	1.79	0.30	0.60	0.30	0.30
heart - pulmonic valve, adult	10206-103F8	48.37	12.81	4.71	2.35	1.05	4.71	1.83	0.00	1.31	0.00
heart - tricuspid valve, adult	10207-103F9	48.29	8.33	2.50	1.67	0.83	1.67	0.83	0.00	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	72.85	7.55	2.65	1.02	1.02	2.24	1.22	0.82	0.20	0.20
heart, adult, diseased, donor1	10051-101G6	59.19	11.92	1.70	0.85	0.43	2.55	0.85	1.28	0.85	0.43
heart, adult, pool1	10016-101C7	41.63	14.26	2.99	0.92	2.07	5.29	1.15	0.69	0.92	0.69
heart, fetal, pool1	10046-101G1	50.01	16.53	7.70	2.26	3.39	3.70	0.72	2.36	1.54	1.23
hepatic mesenchymal tumor cell line:LI90	10778-110G4	56.15	15.43	2.16	2.47	0.93	1.23	0.93	0.31	0.31	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	97.51	4.76	1.19	0.00	0.00	1.19	0.00	1.19	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	112.71	20.11	5.64	1.22	4.42	1.55	4.97	2.43	0.99	0.66
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	112.15	21.12	5.22	1.70	3.40	2.67	4.85	2.43	0.97	0.61
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	108.33	20.61	6.47	0.81	4.04	2.43	6.57	2.83	0.71	0.81
hepatoma cell line:Li-7	10484-107A7	29.14	5.89	6.23	1.89	2.67	1.67	0.89	1.22	1.22	0.78
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	17.59	1.21	1.41	1.31	1.21	0.10	0.10	0.00	0.00	0.10
hippocampus - adult, donor10196	10169-103B7	159.93	0.95	12.30	1.89	1.89	0.95	0.00	0.95	2.84	0.00
hippocampus, adult, donor10252	10153-102I9	101.64	5.31	7.14	2.45	5.31	0.41	1.63	2.65	1.63	1.43
hippocampus, adult, donor10258	10374-105G5	82.66	3.98	12.95	7.97	0.50	1.00	0.50	1.00	1.00	0.50
hippocampus, newborn, donor10223	10363-105F3	80.72	4.23	10.22	4.58	7.75	1.41	0.00	6.70	4.23	0.70
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	28.69	18.92	21.97	10.99	6.10	0.61	6.10	4.88	3.05	2.44
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	50.07	10.80	13.35	7.66	5.50	0.59	4.12	3.14	1.77	1.18
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	35.29	13.46	21.33	9.90	5.33	0.25	4.06	2.79	2.29	0.76
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	40.60	3.38	45.67	20.30	3.38	0.00	2.26	7.33	6.77	2.82
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	38.22	3.87	43.12	19.88	9.81	0.00	2.32	10.84	12.39	3.87
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	22.78	2.28	54.66	23.16	5.31	0.00	3.80	11.39	9.87	4.56
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	43.50	2.63	37.66	14.01	1.75	0.29	1.17	7.59	8.76	2.63
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	48.90	0.43	31.88	13.14	6.68	0.22	0.65	7.97	8.83	2.15
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	50.47	2.50	32.11	10.43	4.17	0.00	0.42	9.18	7.09	3.75
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	38.36	4.26	36.47	11.13	4.74	0.95	1.42	16.58	7.34	3.55
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	67.34	3.38	27.48	8.36	6.59	0.64	1.77	11.09	7.23	4.82
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	48.48	3.37	30.30	9.43	0.67	0.00	0.67	7.41	4.04	5.39
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	34.27	7.04	14.87	6.73	6.42	0.31	3.60	4.07	4.38	1.56
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	41.76	6.88	20.14	10.32	4.42	0.98	2.46	2.95	4.42	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	12.22	6.98	25.31	9.60	6.98	0.00	6.11	2.62	1.75	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	42.95	4.39	57.46	15.46	9.93	0.00	2.29	13.36	14.32	5.73
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	46.22	2.18	46.22	17.01	8.29	0.00	1.74	11.34	16.13	6.11
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	33.98	6.50	56.47	28.49	4.50	1.00	4.00	15.49	8.00	5.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	31.46	1.32	24.49	10.93	5.84	0.00	0.38	6.22	6.22	1.13
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	41.83	1.82	30.01	12.73	4.09	0.00	0.00	4.09	5.91	0.45
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	35.71	0.63	33.83	13.78	4.39	0.00	0.31	5.95	3.76	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	56.18	2.78	23.84	8.65	5.88	0.65	0.65	10.61	8.00	4.08
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	49.64	0.87	29.90	6.39	3.48	0.00	0.58	6.68	5.81	4.35
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	65.46	3.59	28.40	10.46	5.38	0.30	1.20	6.88	3.89	4.18
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	38.24	5.54	14.78	5.73	7.39	0.55	4.80	4.80	4.25	0.92
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	65.04	6.56	18.26	4.85	7.99	0.57	4.28	3.99	3.71	1.14
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	32.66	12.25	22.46	11.84	5.72	0.41	6.12	4.08	3.67	2.04
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	39.79	4.93	34.50	10.21	7.75	0.70	2.11	12.32	6.34	3.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	43.71	4.75	34.21	11.40	6.97	0.00	2.53	6.33	8.24	2.53
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	34.80	6.36	35.71	13.62	4.54	0.30	1.51	8.17	7.87	5.75
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	37.75	0.00	17.07	5.69	4.14	0.00	1.03	4.14	6.72	1.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	50.48	1.99	21.92	7.31	5.31	0.66	0.00	5.98	6.64	5.98
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	27.71	3.85	24.88	10.00	2.05	0.26	0.77	6.16	4.36	2.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	45.51	6.39	24.03	7.16	3.83	1.79	0.77	8.95	3.58	2.05
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	58.31	3.79	27.26	8.33	4.54	0.76	2.27	8.33	11.36	1.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	57.80	7.06	28.56	10.42	6.05	1.68	1.01	8.74	6.72	4.37
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	41.78	5.31	16.18	5.07	7.73	0.72	3.14	3.38	4.59	0.97
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	27.63	6.68	19.16	8.91	7.58	0.00	6.68	3.57	3.57	1.78
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	49.27	11.71	22.93	6.83	5.37	1.46	3.41	4.39	1.46	0.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	32.40	2.44	37.90	12.84	7.03	0.31	1.83	11.31	9.17	2.14
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	19.52	0.00	74.82	97.60	22.77	0.00	0.00	6.51	9.76	9.76
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	17.87	4.96	61.89	19.53	6.62	0.00	4.63	8.27	4.96	4.30
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	38.86	2.19	27.91	5.47	4.38	0.00	0.55	1.64	5.47	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	31.12	0.36	31.85	16.28	2.17	0.00	1.45	4.70	5.79	1.81
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	25.98	0.36	26.33	11.39	4.63	0.00	1.07	6.76	3.56	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	44.16	0.00	14.32	5.97	8.35	0.00	2.39	7.16	5.97	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	57.69	2.84	30.74	10.29	5.55	0.54	0.54	8.94	6.64	3.79
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	50.38	4.31	22.09	9.16	3.23	0.54	1.62	6.20	2.96	3.77
immature langerhans cells, donor1	11904-125F5	18.89	5.81	7.75	7.26	1.94	0.97	0.97	0.24	0.00	0.00
immature langerhans cells, donor2	11905-125F6	37.23	3.96	6.34	7.13	1.58	0.79	1.58	0.00	0.00	0.00
insula, adult, pool1	10039-101F3	60.94	7.00	10.69	2.65	3.60	0.76	0.95	2.18	1.32	1.32
keratoacanthoma cell line:HKA-1	10791-110H8	37.39	3.25	1.95	4.88	0.98	0.33	0.33	0.33	0.33	0.00
kidney, adult, pool1	10017-101C8	46.46	15.72	4.21	1.50	1.60	4.41	2.40	0.40	0.50	0.80
kidney, fetal, pool1	10045-101F9	52.27	13.09	7.43	4.03	2.05	2.48	1.77	1.91	2.19	1.77
large cell lung carcinoma cell line:IA-LM	10509-107D5	22.72	18.89	6.96	4.12	2.27	3.69	4.26	0.99	1.99	0.85
large cell lung carcinoma cell line:NCI-H460	10839-111E2	12.44	2.35	1.11	2.07	0.97	0.55	0.41	0.41	0.28	0.28
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	55.78	8.62	5.87	3.30	1.10	2.02	1.83	2.02	0.73	0.18
left atrium, adult, donor1	10079-102A7	79.00	5.45	5.99	2.72	1.63	2.72	0.00	1.09	2.18	0.00
left ventricle, adult, donor1	10078-102A6	73.83	6.07	3.03	3.03	1.52	2.53	0.00	1.52	2.02	0.51
leiomyoblastoma cell line:G-402	10721-110A1	94.12	13.68	10.67	1.64	5.47	3.28	3.83	2.19	1.92	0.82
leiomyoma cell line:10964C	10569-108B2	19.40	3.95	4.67	2.51	1.80	0.72	0.72	0.36	1.44	1.80
leiomyoma cell line:15242A	10570-108B3	21.20	4.35	2.72	1.63	2.72	0.00	1.09	0.00	0.54	0.54
leiomyoma cell line:15425	10571-108B4	31.81	9.23	4.37	5.58	2.43	4.37	1.46	4.86	2.19	1.94
leiomyosarcoma cell line:Hs 5.T	10722-110A2	19.05	0.00	0.00	0.00	0.00	0.00	6.35	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	44.96	10.46	5.23	4.18	3.14	3.14	4.18	0.00	3.14	1.05
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	34.83	13.10	3.07	2.36	2.60	1.77	2.72	0.47	0.00	0.00
liposarcoma cell line:KMLS-1	10782-110G8	57.80	17.81	5.62	5.78	2.34	2.81	2.66	3.12	2.03	1.56
liposarcoma cell line:SW 872	10726-110A6	92.84	16.69	4.39	2.31	1.10	2.44	2.07	1.58	1.10	1.34
liver, adult, pool1	10018-101C9	42.62	9.24	6.48	1.13	1.78	2.27	0.49	0.16	0.16	0.16
liver, fetal, pool1	10086-102B5	54.56	6.58	1.88	1.88	2.82	1.88	0.00	0.94	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	86.91	3.50	6.85	1.90	4.67	1.17	0.87	2.04	0.58	1.31
locus coeruleus, adult, donor10252	10165-103B3	53.89	4.24	3.69	1.29	3.14	0.18	0.74	1.66	0.18	1.48
locus coeruleus, adult, donor10258	10375-105G6	60.38	3.10	5.36	3.10	3.67	1.41	0.28	3.10	1.69	0.56
locus coeruleus, newborn, donor10223	10362-105F2	34.91	2.94	13.88	3.36	5.47	0.00	0.42	0.00	0.00	0.84
lung adenocarcinoma cell line:A549	10499-107C4	23.94	7.47	2.91	0.97	1.38	0.42	1.94	0.00	0.14	0.14
lung adenocarcinoma cell line:PC-14	10408-106B3	288.86	137.88	5.52	1.38	4.83	25.51	21.37	3.45	0.69	1.38
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	100.58	19.64	11.86	5.40	3.16	4.22	3.95	0.79	0.13	0.13
lung, adult, pool1	10019-101D1	32.96	10.87	3.31	1.89	1.42	1.77	0.95	0.47	0.12	0.00
lung, fetal, donor1	10068-101I5	54.80	13.41	13.13	4.85	2.00	5.42	0.57	0.86	1.14	0.00
lung, right lower lobe, adult, donor1	10075-102A3	80.19	6.87	3.21	0.92	1.83	1.37	0.92	0.00	0.00	0.00
lymph node, adult, donor1	10077-102A5	67.22	6.15	3.31	1.89	1.89	1.42	0.00	0.00	0.00	0.00
lymphangiectasia cell line:DS-1	10727-110A7	33.10	9.21	1.97	1.97	3.07	0.22	2.19	0.44	0.22	0.44
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	39.39	6.79	4.83	0.75	7.70	0.45	1.66	0.91	0.60	0.45
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	45.02	18.69	2.55	0.85	1.70	3.40	1.70	0.00	0.00	0.00
mature adipocyte, donor1	12231-129F8	79.92	19.54	4.44	0.89	2.22	6.66	0.44	0.44	0.00	0.00
mature adipocyte, donor2	12232-129F9	49.39	14.94	2.91	1.66	2.28	4.15	1.25	0.62	0.21	0.00
mature adipocyte, donor3	12233-129G1	59.03	12.33	4.27	1.42	1.19	3.79	0.47	0.47	0.24	0.24
mature adipocyte, donor4	12234-129G2	50.27	8.69	7.11	2.63	1.84	5.00	1.32	0.53	0.53	0.26
maxillary sinus tumor cell line:HSQ-89	10414-106B9	135.33	26.69	5.96	0.48	6.91	2.14	4.29	0.24	0.71	0.24
medial frontal gyrus - adult, donor10196	10170-103B8	127.47	7.90	7.90	5.64	3.38	1.13	0.00	1.13	1.13	5.64
medial frontal gyrus, adult, donor10252	10150-102I6	102.07	5.33	8.28	2.76	3.49	0.55	1.47	2.39	0.92	1.84
medial frontal gyrus, adult, donor10258	10368-105F8	132.16	6.99	10.48	6.67	1.27	0.64	1.59	1.59	2.54	1.59
medial frontal gyrus, newborn, donor10223	10352-105E1	41.80	2.13	16.63	8.10	4.26	0.00	0.85	1.28	0.00	0.85
medial temporal gyrus - adult, donor10196	10183-103D3	138.38	6.08	15.53	6.08	5.06	0.84	2.03	2.03	1.01	2.03
medial temporal gyrus, adult, donor10252	10156-103A3	99.53	5.94	6.37	2.55	4.88	1.91	1.06	1.91	1.06	2.76
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	115.58	3.85	5.78	5.78	1.93	1.93	0.00	0.00	1.93	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	28.71	0.00	0.00	14.35	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	98.71	1.44	8.97	6.46	3.23	0.72	0.72	1.79	1.79	1.44
medulla oblongata - adult, donor10196	10174-103C3	95.40	5.19	1.95	1.95	1.30	0.65	1.30	1.95	2.60	0.65
medulla oblongata, adult, donor10252	10155-103A2	62.70	6.35	2.79	1.24	2.32	0.62	1.55	1.39	0.62	0.46
medulla oblongata, adult, pool1	10038-101F2	38.77	5.14	5.96	2.04	2.69	0.57	0.73	0.90	0.49	0.73
medulla oblongata, newborn, donor10223	10361-105F1	50.34	2.78	5.21	2.08	3.12	1.39	0.69	3.47	2.08	0.69
medulloblastoma cell line:D283 Med	10838-111E1	35.43	3.54	7.09	1.55	3.54	0.66	0.00	2.66	0.89	0.00
medulloblastoma cell line:ONS-76	10759-110E3	106.87	6.11	6.36	8.68	1.22	2.69	1.22	11.37	7.95	5.99
melanoma cell line:COLO 679	10514-107E1	25.16	4.74	2.73	2.01	0.86	0.14	1.15	0.14	0.14	0.00
melanoma cell line:G-361	10465-106H6	19.00	2.71	2.99	2.71	2.71	0.54	0.27	0.54	0.00	0.27
meningioma cell line:HKBMM	10691-109F7	15.56	8.14	3.26	5.07	0.90	0.54	0.90	1.45	0.54	1.45
merkel cell carcinoma cell line:MKL-1	10843-111E6	66.09	7.93	21.15	2.64	2.64	1.76	0.88	4.41	1.76	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	43.55	16.07	19.18	7.00	9.85	3.11	4.41	9.59	7.00	3.89
mesenchymal precursor cell - adipose, donor1	11747-123G1	25.32	5.98	6.29	4.76	1.99	1.53	1.53	0.77	0.77	0.31
mesenchymal precursor cell - adipose, donor2	11748-123G2	15.63	3.82	2.18	3.82	0.91	0.91	0.36	0.73	0.18	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	19.46	6.63	10.35	9.52	2.07	1.24	0.83	0.83	1.24	0.83
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	19.39	9.27	2.95	4.21	1.69	2.67	1.26	2.95	1.26	0.42
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	19.83	14.25	3.47	3.08	2.12	2.12	1.35	1.73	0.77	0.19
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	40.26	14.58	6.25	5.55	4.16	9.02	0.69	10.41	3.47	2.78
mesenchymal precursor cell - cardiac, donor1	11752-123G6	14.93	7.90	2.40	1.89	1.72	1.72	1.03	0.69	0.17	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	23.81	9.09	3.45	3.45	1.61	2.53	1.38	1.38	1.15	0.35
mesenchymal precursor cell - cardiac, donor3	11754-123G8	26.13	7.83	4.64	3.05	2.25	1.86	0.66	0.93	1.19	0.27
mesenchymal precursor cell - cardiac, donor4	11755-123G9	20.66	6.08	2.97	3.65	2.57	1.62	1.89	1.08	0.68	0.27
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	17.21	5.83	1.56	2.85	1.99	0.85	1.28	0.71	0.43	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	26.68	10.21	2.63	4.61	1.32	1.32	0.66	0.66	0.33	0.99
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	25.46	6.64	3.04	2.35	2.21	0.83	1.25	1.25	0.28	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	24.44	6.63	5.93	4.54	1.05	2.44	1.75	3.84	1.05	0.70
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	15.92	5.92	1.43	2.86	0.82	1.63	0.82	0.20	0.82	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	20.13	6.47	3.59	2.16	1.08	1.80	1.80	0.72	0.72	1.44
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	18.31	6.83	1.55	2.07	1.14	0.62	1.45	0.41	0.52	0.10
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	14.82	7.07	2.51	2.05	0.68	1.60	0.91	0.68	0.68	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	12.59	3.78	6.71	3.36	1.26	0.42	0.84	0.42	0.00	0.42
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	15.54	7.17	2.39	4.33	2.09	2.39	1.20	1.49	1.05	0.15
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	22.76	10.50	2.98	2.54	1.66	2.54	1.58	0.26	0.44	0.26
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	22.46	7.73	1.47	1.10	0.74	1.10	1.47	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	22.61	5.44	2.58	2.29	0.29	1.72	1.72	0.86	0.57	1.14
mesenchymal stem cell line:Hu5/E18	10568-108B1	46.31	11.79	8.84	8.84	5.47	5.05	3.37	0.84	1.26	2.11
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	31.97	10.96	4.11	2.28	0.46	4.11	0.46	1.83	1.83	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	29.16	11.51	6.39	4.86	1.28	7.42	1.28	3.07	1.02	1.02
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	35.34	12.04	5.50	3.93	1.83	7.85	1.05	2.88	1.31	1.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	30.19	10.47	5.24	3.08	3.08	6.78	1.23	1.54	0.62	0.92
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	27.07	12.71	3.77	1.41	1.41	4.71	1.18	2.12	0.71	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	38.58	12.86	6.09	4.40	0.34	6.09	1.35	2.03	1.02	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	28.69	11.79	6.68	3.93	1.96	4.72	1.96	2.75	2.75	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	26.88	8.80	2.78	4.63	1.39	3.71	2.32	2.32	1.85	1.85
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	42.40	14.71	4.90	2.60	2.02	4.61	1.73	2.02	1.73	2.60
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	31.01	13.61	5.35	2.90	0.67	6.02	0.89	1.78	1.12	0.89
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	30.52	12.50	5.53	2.16	1.20	8.17	1.20	2.64	0.72	1.44
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	55.73	13.20	4.40	3.67	2.93	5.13	1.47	2.93	1.47	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	28.20	11.08	5.71	3.36	2.01	5.37	0.00	1.34	0.34	1.68
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	27.84	9.42	5.73	1.23	1.23	6.55	0.41	0.41	0.41	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	26.20	12.03	6.87	1.29	2.58	4.73	1.72	2.15	0.86	0.86
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	24.61	5.47	2.73	5.47	2.73	5.47	0.00	0.00	5.47	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	25.82	10.33	0.00	0.00	0.00	10.33	0.00	5.16	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	29.56	11.04	5.52	3.25	0.65	5.52	0.97	0.97	0.97	1.30
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	24.73	11.64	1.45	2.91	0.00	2.91	0.00	1.45	2.91	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	31.98	12.26	3.73	4.26	0.53	9.06	1.60	2.13	1.60	1.07
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	24.53	8.18	3.27	3.27	1.64	3.27	1.64	3.27	1.64	2.45
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	32.65	9.33	5.83	5.05	0.00	5.44	0.39	3.89	1.94	1.17
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	16.79	10.49	2.10	2.10	0.00	4.20	2.10	2.10	2.10	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	16.89	8.94	8.94	2.98	1.99	0.99	0.00	1.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	28.60	9.53	9.53	9.53	0.00	0.00	0.00	4.77	4.77	9.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	36.17	4.74	7.12	4.15	3.56	4.15	1.19	3.56	2.37	1.78
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	21.93	13.40	4.87	3.66	0.00	6.09	1.22	3.66	0.00	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	54.10	0.00	0.00	27.05	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	24.70	12.67	2.53	5.07	1.27	5.07	0.63	3.17	2.53	1.90
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	37.59	8.62	9.66	3.79	0.69	10.00	0.69	3.45	1.03	1.38
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	21.49	8.60	6.45	0.00	0.00	6.45	0.00	0.00	2.15	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	23.95	19.96	3.99	7.98	0.00	3.99	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	58.55	17.22	10.33	3.44	3.44	0.00	0.00	3.44	3.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	29.75	11.82	4.89	1.63	1.22	5.70	0.81	2.04	2.04	2.44
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	23.83	11.92	5.56	3.18	0.79	3.18	0.00	3.18	1.59	3.18
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	26.53	7.66	8.25	2.36	0.59	5.31	1.18	2.36	0.59	2.36
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	38.03	9.97	4.05	2.81	1.25	3.43	1.25	2.49	1.56	1.87
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	28.07	5.35	4.01	1.34	0.00	0.00	0.00	0.00	1.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	37.85	3.55	2.37	2.37	0.00	3.55	1.18	1.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	23.11	7.70	0.00	2.57	2.57	7.70	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	26.85	10.33	4.13	4.82	0.00	2.07	0.00	0.69	0.00	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	40.57	10.39	2.47	1.98	1.48	2.97	0.49	0.99	0.00	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	41.50	6.73	3.36	0.00	1.12	2.24	0.00	1.12	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	38.16	8.27	5.09	2.54	0.64	3.18	0.00	0.64	0.00	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	48.76	14.10	2.82	0.81	0.81	2.42	1.21	0.00	0.40	0.40
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	43.61	10.90	2.18	2.18	0.00	2.18	0.00	2.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	45.61	16.47	3.80	2.53	1.27	6.34	1.27	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	46.12	4.86	4.25	1.21	0.61	0.61	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	81.34	18.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	42.01	4.12	2.47	1.65	0.00	4.94	2.47	0.00	0.00	0.82
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	45.64	11.11	8.14	4.17	2.98	3.37	0.40	2.18	2.78	2.58
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	42.18	9.09	7.46	3.24	0.97	5.84	0.97	3.57	1.95	1.62
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	51.95	10.19	4.07	2.04	1.02	4.07	1.02	4.07	1.02	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	75.82	29.40	3.09	1.55	1.55	10.83	4.64	0.77	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	88.12	17.01	4.72	0.24	4.72	1.42	1.65	0.00	0.47	0.24
mesothelioma cell line:ACC-MESO-4	10494-107B8	46.10	22.94	4.63	1.16	3.94	3.94	3.94	0.93	1.62	1.16
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	34.19	8.55	8.55	4.27	4.27	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	35.45	9.97	2.36	1.95	2.26	3.29	1.64	0.51	0.10	0.21
mesothelioma cell line:Mero-25	10850-111F4	6.35	4.31	0.68	1.59	0.23	0.68	1.13	0.23	0.00	0.00
mesothelioma cell line:Mero-41	10851-111F5	54.76	17.85	1.71	3.18	1.22	4.65	1.47	0.73	0.49	0.00
mesothelioma cell line:Mero-48a	10852-111F6	29.89	9.30	1.99	1.11	0.89	1.33	1.99	0.22	0.00	0.22
mesothelioma cell line:Mero-82	10853-111F7	47.30	14.19	1.84	2.37	2.37	2.63	0.79	0.00	0.79	0.00
mesothelioma cell line:Mero-83	10854-111F8	20.77	7.66	1.70	1.19	1.53	2.04	0.85	0.17	0.17	0.00
mesothelioma cell line:Mero-84	10855-111F9	15.92	2.78	2.02	0.76	0.25	0.25	0.51	0.00	0.25	0.00
mesothelioma cell line:Mero-95	10856-111G1	24.43	7.66	1.45	2.07	0.41	1.66	1.45	0.00	0.21	0.41
mesothelioma cell line:NCI-H2052	10847-111F1	56.65	9.28	2.15	3.15	0.83	2.48	1.33	0.33	0.33	0.99
mesothelioma cell line:NCI-H226	10846-111E9	21.90	9.41	1.63	3.26	1.27	1.45	1.63	0.90	0.54	0.18
mesothelioma cell line:NCI-H2452	10848-111F2	19.30	14.52	0.85	1.20	0.34	1.54	0.85	0.17	0.34	0.17
mesothelioma cell line:NCI-H28	10845-111E8	20.36	10.43	2.04	2.54	1.78	1.53	2.80	0.25	0.00	0.76
mesothelioma cell line:No36	10857-111G2	27.73	10.11	2.28	0.65	0.65	0.00	1.96	0.98	0.00	0.00
mesothelioma cell line:ONE58	10858-111G3	42.81	11.65	3.25	2.71	2.17	3.52	2.17	0.00	0.00	0.27
migratory langerhans cells, donor1	11901-125F2	12.47	3.65	1.34	0.58	2.49	0.00	0.77	0.00	0.00	0.00
migratory langerhans cells, donor2	11902-125F3	18.32	1.71	1.10	0.37	2.32	0.24	0.85	0.12	0.12	0.00
migratory langerhans cells, donor3	11903-125F4	20.82	5.92	1.97	0.54	3.23	0.18	1.44	0.18	0.00	0.18
mixed mullerian tumor cell line:HTMMT	10689-109F5	16.65	4.90	0.65	0.33	0.33	0.98	0.65	0.00	0.00	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	26.92	10.60	3.39	0.85	1.91	0.21	0.64	1.27	0.42	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	277.12	31.10	10.83	19.35	4.61	8.52	5.07	5.53	1.15	2.07
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	37.68	6.85	2.47	2.66	4.00	0.19	0.95	0.19	0.76	0.57
myelodysplastic syndrome cell line:SKM-1	10772-110F7	45.64	7.39	11.64	11.27	4.62	0.92	2.22	0.92	0.74	0.74
myeloma cell line:PCM6	10474-106I6	37.75	9.29	2.97	0.20	2.17	0.40	0.99	0.20	0.00	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	99.43	17.76	8.62	2.54	1.01	2.54	3.55	0.00	1.01	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	95.52	11.57	6.86	6.28	0.78	4.32	1.18	4.71	1.77	3.53
nasal epithelial cells, donor1, tech_rep1	12226-129F3	16.83	2.34	0.78	1.23	0.33	0.11	0.45	0.00	0.00	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	14.78	2.72	1.32	1.18	1.18	0.00	0.51	0.07	0.07	0.00
nasal epithelial cells, donor2	12227-129F4	39.74	4.97	1.66	2.76	0.00	1.66	0.55	0.55	0.55	0.55
neuroblastoma cell line:CHP-134	10508-107D4	67.18	6.67	14.03	1.61	7.13	0.69	1.61	2.53	3.45	0.69
neuroblastoma cell line:NB-1	10539-107G8	48.27	7.67	14.59	8.79	9.54	1.31	1.68	4.30	2.62	1.87
neuroblastoma cell line:NBsusSR	10607-108F4	20.88	2.11	1.90	0.42	2.11	0.21	0.42	0.84	0.42	0.42
neuroblastoma cell line:NH-12	10555-107I6	51.25	6.34	8.39	2.61	6.52	1.12	0.75	2.24	2.42	1.12
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	82.79	3.56	16.13	6.17	7.12	0.47	1.66	4.27	3.32	2.61
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	56.07	5.86	3.96	0.95	1.58	0.48	1.11	0.79	0.16	0.32
neuroectodermal tumor cell line:TASK1	10774-110F9	60.38	13.28	2.42	1.21	2.82	2.82	1.41	1.41	0.40	0.40
neuroepithelioma cell line:SK-N-MC	10728-110A8	160.85	1.91	6.99	5.09	3.81	0.00	0.00	2.54	3.81	1.91
neurofibroma cell line:Hs 53.T	10729-110A9	51.10	9.32	1.06	1.06	2.13	2.66	1.86	0.53	0.27	0.53
neutrophil PMN, donor1	12133-128D9	14.87	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	26.56	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	22.49	7.95	11.50	10.32	10.99	0.51	2.37	2.03	1.86	0.68
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	53.63	24.02	25.62	8.01	8.01	12.81	3.20	17.61	3.20	7.20
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	54.82	14.75	6.41	3.85	2.24	2.56	0.64	5.77	4.49	2.24
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	39.41	9.99	4.47	2.63	2.10	2.36	2.63	1.31	0.26	0.26
nucleus accumbens, adult, pool1	10037-101F1	57.46	5.91	10.12	3.00	3.28	1.22	0.94	1.50	0.94	0.56
occipital cortex - adult, donor10196	10172-103C1	156.59	4.12	16.48	8.24	0.00	0.00	2.06	4.12	4.12	2.06
occipital cortex, adult, donor10252	10163-103B1	102.25	4.83	7.78	2.95	2.68	0.54	0.81	2.42	2.15	2.42
occipital cortex, newborn, donor10223	10355-105E4	74.24	3.28	14.56	4.37	4.37	0.00	0.36	1.82	1.82	1.46
occipital lobe, adult, donor1	10076-102A4	124.64	3.15	34.37	6.04	7.87	0.79	1.57	4.72	1.84	1.57
occipital lobe, fetal, donor1	10073-102A1	288.78	6.44	34.33	12.44	15.45	3.00	0.43	20.60	21.03	5.15
occipital pole, adult, pool1	10036-101E9	52.98	6.07	10.96	3.94	2.37	0.95	1.34	2.76	0.55	1.89
olfactory region, adult	10195-103E6	65.15	4.01	10.13	2.48	4.01	0.57	0.57	2.10	0.57	0.76
optic nerve, donor1	10277-104E7	84.04	0.00	26.01	6.00	8.00	4.00	0.00	2.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	37.70	25.29	5.01	3.30	0.91	1.25	5.35	0.80	0.00	0.34
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	23.36	5.22	9.89	2.06	2.75	0.55	1.79	2.20	2.06	0.69
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	23.37	5.59	1.86	1.35	0.51	0.17	1.69	0.17	0.17	0.17
oral squamous cell carcinoma cell line:SAS	10544-107H4	22.41	4.39	0.92	2.31	1.27	0.46	0.58	0.23	0.12	0.00
osteoclastoma cell line:Hs 706.T	10704-109H2	41.16	19.99	4.41	2.35	3.53	4.70	3.53	2.65	1.18	0.88
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	181.26	27.10	15.88	4.67	6.54	4.67	8.41	2.80	1.87	0.93
osteosarcoma cell line:HS-Os-1	10558-107I9	11.66	14.63	2.33	0.64	2.76	4.88	1.27	0.21	0.42	0.42
ovary, adult, pool1	10020-101D2	28.83	6.38	4.63	2.10	0.96	1.92	0.09	0.52	0.26	0.35
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	46.56	6.23	1.65	2.20	0.55	0.55	1.65	0.55	0.92	0.18
pancreas, adult, donor1	10049-101G4	55.50	4.70	5.64	2.82	1.88	4.70	0.00	0.00	0.00	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	27.67	0.84	4.75	1.12	2.80	0.00	0.00	0.00	0.28	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	24.19	7.50	0.85	2.56	1.53	1.19	0.85	0.00	0.00	0.00
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	23.18	14.57	7.12	5.63	3.31	1.82	3.97	0.83	0.33	0.33
paracentral gyrus, adult, pool1	10035-101E8	52.17	7.50	10.98	3.94	2.93	0.27	1.01	2.11	1.19	1.10
parietal cortex, adult, donor10258	10373-105G4	68.26	4.40	12.48	5.14	0.00	0.73	0.73	0.00	2.20	0.00
parietal lobe - adult, donor10196	10171-103B9	91.23	3.76	10.35	9.40	0.94	0.00	0.00	5.64	1.88	1.88
parietal lobe, adult, donor10252	10157-103A4	82.38	4.85	8.84	2.00	2.57	1.14	0.86	1.14	0.00	2.00
parietal lobe, adult, pool1	10034-101E7	52.08	5.55	9.16	2.73	3.00	0.79	1.67	2.56	0.88	1.32
parietal lobe, fetal, donor1	10072-101I9	328.77	6.79	33.94	6.79	15.52	1.94	0.97	18.43	18.43	1.94
parietal lobe, newborn, donor10223	10356-105E5	62.06	3.36	14.21	4.11	3.36	0.75	1.87	2.62	1.12	1.12
parotid gland, adult	10199-103F1	37.62	8.02	0.00	1.85	0.00	4.32	0.00	1.85	0.62	1.23
penis, adult	10200-103F2	30.08	3.76	5.91	3.22	0.00	1.61	1.07	0.00	0.00	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	8.18	2.05	1.49	0.19	3.35	0.00	0.00	0.00	0.00	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	66.00	20.54	2.04	5.39	1.31	2.04	3.79	1.46	1.60	2.19
pineal gland - adult, donor10196	10179-103C8	329.61	17.42	14.19	16.77	5.81	0.00	1.29	8.39	3.87	3.23
pineal gland, adult, donor10252	10160-103A7	231.56	10.66	21.32	8.88	8.29	1.18	1.78	5.92	2.96	1.18
pineal gland, adult, donor10258	10377-105G8	149.87	8.78	26.34	20.69	6.27	0.63	4.39	6.90	0.63	3.76
pituitary gland - adult, donor10196	10180-103C9	98.14	5.06	5.06	1.01	2.02	0.00	4.05	0.00	1.01	0.00
pituitary gland, adult, donor10252	10162-103A9	99.55	10.94	5.73	1.56	1.56	1.04	1.56	0.52	0.00	0.00
pituitary gland, adult, donor10258	10378-105G9	45.97	10.21	17.02	2.55	3.40	0.85	1.70	2.55	0.00	0.00
placenta, adult, pool1	10021-101D3	36.55	5.70	2.90	2.58	1.29	0.97	0.54	0.43	0.22	0.11
plasma cell leukemia cell line:ARH-77	10840-111E3	24.10	4.37	2.38	1.99	5.03	0.13	1.32	0.66	0.40	0.66
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	78.91	31.44	4.20	2.33	3.27	15.72	2.02	1.56	1.25	1.56
pons, adult, pool1	10033-101E6	30.73	4.05	4.91	1.12	2.93	0.43	1.12	0.95	1.03	0.17
postcentral gyrus, adult, pool1	10032-101E5	48.38	6.28	12.38	3.92	3.05	0.26	1.48	1.83	1.66	2.01
promyelocytes/myelocytes PMC, donor1	12132-128D8	48.10	31.37	8.37	0.00	2.09	6.27	10.46	0.00	2.09	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	0.00	11.02	0.00	5.51	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	11.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	30.73	4.81	5.39	1.60	3.93	0.73	1.31	0.15	0.58	0.29
prostate cancer cell line:PC-3	10439-106E7	119.25	15.06	9.62	5.08	2.72	5.45	2.18	6.90	5.08	2.72
prostate, adult, pool1	10022-101D4	33.47	10.79	4.53	1.81	1.27	3.45	1.09	0.54	0.54	0.18
putamen, adult, donor10196	10176-103C5	85.46	1.89	11.09	1.18	6.14	0.94	0.47	1.89	1.65	0.71
putamen, adult, donor10252	10152-102I8	25.49	0.00	11.76	1.96	1.96	0.00	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	44.81	2.19	5.46	2.19	1.09	0.00	1.09	0.00	2.19	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	60.40	3.14	7.73	2.42	0.97	1.21	0.48	0.72	0.24	0.24
putamen, newborn, donor10223	10365-105F5	29.24	3.75	20.99	2.25	5.25	0.00	0.00	0.00	0.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	16.00	3.20	0.58	0.58	0.29	0.29	0.87	0.00	0.29	0.00
rectum, fetal, donor1	10067-101I4	182.22	15.30	16.69	12.52	2.78	5.56	0.00	8.35	9.74	2.78
renal cell carcinoma cell line:OS-RC-2	10411-106B6	28.20	7.21	7.84	4.24	2.33	0.85	1.27	0.42	0.42	0.64
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	12.01	2.49	8.28	4.56	2.90	0.00	0.83	0.00	0.41	0.83
retina, adult, pool1	10030-101E3	59.34	13.72	5.17	1.49	2.29	1.49	1.29	1.29	1.19	0.50
retinoblastoma cell line:Y79	10475-106I7	20.78	2.34	5.72	2.60	4.94	0.26	0.78	1.56	0.52	0.26
rhabdomyosarcoma cell line:KYM-1	10787-110H4	67.01	11.68	3.07	1.11	1.97	1.35	2.46	0.37	0.12	0.00
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	73.96	9.84	12.94	5.91	7.59	0.00	1.97	2.25	3.94	0.28
sacrococcigeal teratoma cell line:HTST	10695-109G2	106.86	21.22	2.27	2.27	1.52	3.79	0.76	2.27	0.76	0.00
salivary acinar cells, donor1	11771-123I7	32.53	8.25	2.91	1.94	1.78	1.13	1.46	0.32	0.16	0.16
salivary acinar cells, donor2	11772-123I8	33.18	8.54	3.72	1.79	1.10	1.79	0.14	0.41	0.14	0.14
salivary acinar cells, donor3	11773-123I9	94.67	15.23	3.31	1.32	0.66	6.62	1.99	1.99	0.00	0.00
salivary gland, adult, pool1	10093-102C3	41.18	10.87	4.58	3.43	1.72	1.72	0.57	1.72	0.57	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	15.85	7.93	3.54	2.02	1.26	0.93	2.45	0.25	0.25	0.00
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	28.80	8.93	3.64	3.17	3.17	0.94	2.12	0.59	0.35	0.12
seminal vesicle, adult	10201-103F3	47.09	9.52	1.06	2.65	2.65	3.17	1.59	0.00	0.53	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	25.75	30.37	7.29	3.16	2.92	5.83	2.67	0.97	0.00	0.73
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	38.25	17.11	2.52	3.77	1.01	2.77	1.26	0.00	0.00	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	52.18	13.05	6.02	7.02	0.00	1.00	2.01	3.01	2.01	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	15.85	4.57	1.48	1.21	0.81	0.00	0.13	0.54	0.40	0.54
signet ring carcinoma cell line:Kato III	10436-106E4	28.63	5.53	3.54	2.21	1.22	0.99	0.55	0.11	0.11	0.00
signet ring carcinoma cell line:NUGC-4	10483-107A6	20.90	14.45	4.52	5.68	0.90	2.06	2.06	0.39	0.26	0.13
skeletal muscle - soleus muscle, donor1	10282-104F3	98.60	4.97	5.67	2.84	1.42	1.42	0.00	0.00	0.71	0.00
skeletal muscle, adult, pool1	10023-101D5	69.68	9.00	12.83	3.48	1.80	3.84	0.36	0.36	0.12	0.12
skeletal muscle, fetal, donor1	10066-101I3	147.74	3.02	9.05	5.03	2.01	2.01	4.02	8.04	4.02	4.02
skin, adult, donor1	10074-102A2	101.78	0.00	20.36	6.79	6.79	6.79	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	116.78	7.57	10.73	3.79	5.68	1.89	1.26	5.68	2.52	1.89
small cell cervical cancer cell line:HCSC-1	10800-110I8	77.38	19.68	2.00	0.00	3.67	0.33	1.67	1.67	1.67	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	139.64	17.34	9.46	5.04	11.98	8.83	3.78	7.56	2.21	1.58
small cell lung carcinoma cell line:DMS 144	10841-111E4	58.21	1.16	4.24	0.58	2.31	0.00	0.77	0.77	1.16	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	65.93	5.93	12.20	2.80	5.93	0.82	2.64	0.82	0.99	1.65
small cell lung carcinoma cell line:NCI-H82	10842-111E5	27.34	2.25	4.66	2.73	6.11	0.32	0.32	0.64	0.97	0.32
small cell lung carcinoma cell line:WA-hT	10562-108A4	90.22	5.23	8.06	9.59	3.27	1.31	1.09	4.14	0.44	2.62
small intestine, adult, pool1	10024-101D6	70.83	7.64	5.14	2.15	1.91	2.99	0.84	0.12	0.12	0.00
small intestine, fetal, donor1	10064-101I1	138.57	8.11	6.39	2.46	2.21	0.49	1.72	0.74	1.72	1.23
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	20.00	8.72	0.51	0.51	1.03	1.54	1.03	0.00	0.51	0.00
smooth muscle, adult, pool1	10048-101G3	45.49	4.91	2.58	3.36	0.26	1.29	0.26	0.26	0.00	0.00
somatostatinoma cell line:QGP-1	10781-110G7	85.77	16.08	5.36	2.95	2.68	0.80	2.41	1.07	0.27	0.27
spinal cord - adult, donor10196	10181-103D1	134.66	4.13	11.93	3.21	4.59	0.46	0.69	0.69	1.38	0.69
spinal cord, adult, donor10252	10159-103A6	68.60	3.94	6.31	1.97	1.58	0.79	0.79	1.18	0.39	0.79
spinal cord, adult, donor10258	10369-105F9	47.04	2.77	10.38	6.23	0.69	0.69	0.69	0.00	0.69	0.00
spinal cord, fetal, donor1	10056-101H2	111.60	7.93	12.20	3.05	3.66	0.00	1.22	4.88	4.88	2.44
spinal cord, newborn, donor10223	10359-105E8	41.33	6.43	7.35	2.30	1.84	0.92	2.30	1.38	0.92	0.92
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	62.58	15.68	2.09	1.79	0.45	1.64	2.24	0.30	0.30	0.00
spleen, adult, pool1	10025-101D7	32.82	11.78	2.53	0.88	2.09	1.32	2.09	0.22	0.11	0.11
spleen, fetal, pool1	10044-101F8	30.59	10.33	2.38	2.15	1.27	1.19	1.43	0.72	0.00	0.08
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	30.12	3.11	1.35	0.72	3.42	0.00	1.45	0.00	0.21	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	20.89	5.13	3.42	1.33	2.28	0.19	0.95	0.00	0.00	0.38
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	63.60	3.84	2.80	1.05	2.10	0.70	1.05	0.00	0.00	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	24.63	3.91	2.35	3.13	1.17	0.39	0.39	0.00	0.78	0.39
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	27.91	13.17	10.58	6.75	3.38	5.97	2.25	2.70	1.58	1.80
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	29.65	5.93	5.93	5.93	1.69	0.00	2.12	0.00	0.00	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	49.08	16.92	6.77	4.23	5.08	2.12	3.81	0.00	0.42	0.42
stomach, fetal, donor1	10062-101H8	263.79	9.61	9.61	6.41	5.34	3.20	0.00	5.34	4.27	2.14
submaxillary gland, adult	10202-103F4	42.16	9.68	6.27	2.85	0.57	2.85	2.85	0.00	0.00	0.57
substantia nigra - adult, donor10196	10178-103C7	54.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	53.59	5.40	5.19	1.25	2.70	1.25	0.83	0.83	0.00	1.04
substantia nigra, adult, donor10258	10371-105G2	64.66	1.55	6.72	3.10	0.00	0.52	0.00	1.55	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	60.06	5.65	7.07	2.12	3.53	2.12	0.00	1.41	0.00	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	27.05	1.60	2.75	1.60	2.29	1.38	0.00	1.60	0.69	1.38
temporal lobe, adult, pool1	10031-101E4	54.59	5.59	10.26	3.31	2.63	0.51	1.44	1.70	1.10	0.76
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	382.49	4.99	19.23	2.85	7.83	0.00	1.42	17.09	11.40	3.56
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	122.63	2.64	14.07	4.40	4.40	1.32	0.88	3.08	8.35	1.76
tenocyte, donor1	11763-123H8	52.71	17.80	2.09	3.84	1.75	4.19	1.40	0.35	0.35	0.70
tenocyte, donor2	11765-123I1	40.82	14.50	2.29	1.91	0.38	4.96	1.14	0.00	0.38	0.38
tenocyte, donor3	11768-123I4	44.85	12.60	1.48	0.74	1.11	3.34	1.48	0.00	0.74	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	41.30	3.91	13.43	5.44	5.78	0.17	1.70	1.19	2.04	1.02
teratocarcinoma cell line:NCR-G1	10798-110I6	44.39	12.18	8.94	8.02	3.85	0.62	2.31	1.54	0.62	1.70
teratocarcinoma cell line:PA-1	10807-111A6	45.87	12.86	8.99	6.82	3.10	0.31	2.48	2.32	2.48	1.24
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	29.20	2.29	6.09	4.95	3.30	0.13	1.40	1.27	1.78	0.38
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	19.29	5.29	3.40	0.00	0.00	0.38	1.89	0.00	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	6.54	1.20	3.60	2.07	2.73	0.11	0.22	0.11	0.22	0.00
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	6.19	0.00	7.17	1.30	3.91	0.00	0.00	0.00	0.00	0.00
testis, adult, pool1	10026-101D8	57.87	8.16	13.10	4.19	2.58	1.61	0.86	1.61	1.93	1.83
testis, adult, pool2	10096-102C6	99.69	3.16	12.18	3.16	3.61	0.45	0.00	3.16	0.90	1.80
thalamus - adult, donor10196	10168-103B6	129.17	5.52	8.83	3.31	0.00	2.21	1.10	1.10	0.00	0.00
thalamus, adult, donor10252	10154-103A1	59.54	3.44	7.03	1.56	2.97	0.94	0.63	2.66	0.63	0.78
thalamus, adult, donor10258, tech_rep1	10370-105G1	92.38	6.16	3.08	1.54	0.00	1.54	0.00	0.00	0.00	1.54
thalamus, adult, donor10258, tech_rep2	10370-105G1	63.90	2.80	3.46	3.13	1.15	0.49	0.49	0.82	1.15	0.16
thalamus, newborn, donor10223	10366-105F6	52.35	4.60	8.05	1.73	7.48	1.15	0.58	1.15	1.15	1.15
throat, adult	10209-103G2	32.96	6.99	6.49	2.50	1.25	2.25	0.75	0.75	0.25	0.75
throat, fetal, donor1	10061-101H7	122.19	9.45	5.48	7.62	3.96	2.44	0.61	5.18	3.96	2.74
thymic carcinoma cell line:Ty-82	10803-111A2	28.62	3.38	5.56	0.99	4.17	0.40	0.79	0.00	0.40	0.40
thymus, adult, pool1	10027-101D9	63.63	10.34	5.96	1.69	4.27	1.19	2.58	0.60	2.29	0.30
thymus, fetal, pool1	10043-101F7	49.25	12.36	5.40	3.01	5.51	1.45	3.01	2.29	1.14	0.31
thyroid carcinoma cell line:KHM-5M	10776-110G2	83.10	15.16	5.05	4.39	2.79	2.79	4.92	0.66	0.53	0.27
thyroid carcinoma cell line:TCO-1	10783-110G9	79.62	15.65	2.24	2.37	1.40	3.77	2.24	0.56	0.70	0.42
thyroid, adult, pool1	10028-101E1	57.67	13.06	2.99	1.68	2.24	2.05	0.65	0.37	0.37	0.19
thyroid, fetal, donor1	10060-101H6	132.36	11.86	5.54	5.01	1.58	1.58	0.53	1.58	1.32	1.85
tongue epidermis (fungiform papillae), donor1	10288-104F9	73.91	0.00	6.16	0.00	0.00	3.08	3.08	0.00	0.00	0.00
tongue, adult	10203-103F5	37.44	12.09	7.68	3.95	1.86	2.33	1.86	0.00	0.23	0.47
tongue, fetal, donor1	10059-101H5	116.65	7.49	5.12	3.55	1.18	1.97	1.58	2.36	0.00	0.79
tonsil, adult, pool1	10047-101G2	38.77	12.32	3.11	1.30	1.90	0.80	1.00	0.70	0.10	0.10
trachea, adult, pool1	10029-101E2	30.18	10.39	3.35	1.47	0.57	2.37	2.13	0.41	0.16	0.08
trachea, fetal, donor1	10058-101H4	90.40	7.31	8.08	4.23	3.08	1.92	0.77	3.08	2.31	0.38
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	56.33	9.57	7.79	4.61	2.83	2.83	2.48	3.90	0.71	1.77
transitional-cell carcinoma cell line:5637	10418-106C4	63.02	10.54	8.92	5.17	3.55	2.63	1.72	2.13	1.72	1.42
transitional-cell carcinoma cell line:JMSU1	10492-107B6	52.02	17.86	9.09	2.98	6.58	2.51	2.66	1.25	0.16	0.16
tridermal teratoma cell line:HGRT	10694-109G1	171.23	20.93	7.61	7.61	3.81	7.61	0.00	11.42	1.90	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	62.13	8.63	2.45	2.54	1.27	1.02	1.69	0.68	0.25	0.08
umbilical cord, fetal, donor1	10057-101H3	81.37	4.17	0.00	4.17	0.00	6.26	2.09	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	37.37	6.14	5.97	1.02	1.37	3.75	0.17	0.34	0.17	0.00
uterus, fetal, donor1	10055-101H1	81.91	6.66	9.21	5.63	3.07	1.54	0.00	7.17	4.61	2.05
vagina, adult	10204-103F6	38.77	10.99	0.65	1.94	0.00	3.23	0.00	0.65	0.00	0.65
vein, adult	10191-103E2	35.29	6.80	2.85	1.53	1.32	0.88	0.44	0.66	0.00	0.00
xeroderma pigentosum b cell line:XPL 17	10563-108A5	28.84	5.34	2.67	0.80	1.60	0.27	1.34	0.53	0.27	0.00